Airbnb, Inc.

ABNB Q3 2025

Reported: 2025-11-07

Airbnb delivered a strong Q3 2025, with revenue growth of 10% year-over-year and record adjusted EBITDA surpassing $2 billion, driven by strategic improvements and international expansion.

Key takeaways

Gross booking value increased 14% year-over-year, with nights booked rising 9%.
Successfully introduced 65 major service improvements, including enhanced payment flexibility and improved mapping features, boosting user experience.
International markets showed strong performance, with average nights booked growing at double the rate of core markets.
Launched service experiences with high customer satisfaction ratings, attracting new users and diversifying offerings.
Initiated a hotel pilot program in key cities, enhancing Airbnb’s portfolio and filling market gaps.

View recap

Archer Aviation Inc. Class A Common Stock

ACHR Q3 2025

Reported: 2025-11-07

Archer Aviation reported strong momentum in Q3 2025, highlighted by the strategic acquisition of Hawthorne Airport and a robust capital raise, positioning the company for rapid scaling and commercialization of its eVTOL technology.

Key takeaways

Secured a definitive agreement to acquire Hawthorne Airport, a key strategic asset located near LAX, enhancing Archer's operational capabilities ahead of the 2028 Olympics.
Successfully raised $650 million in equity capital, bolstering liquidity to over $2 billion.
Advanced testing of the Midnight aircraft, achieving significant milestones in range, flight time, and speeds with ongoing validation of operational performance.
Launched initial commercial operations in Abu Dhabi and established a partnership with Korean Air for up to 100 Midnight aircraft.
Focus on scaling production to meet certification and commercial deployment goals, with plans for 50 aircraft annually.

View recap

Ameren Corporation

AEE Q3 2025

Reported: 2025-11-07

Ameren reported third quarter 2025 adjusted earnings of $2.17 per share, reflecting a strong year-over-year improvement driven by significant infrastructure investment and operational efficiencies.

Key takeaways

Adjusted earnings increased 16% from Q3 2024, aided by a $0.18 tax benefit excluded from adjusted figures.
Over $3 billion deployed in critical infrastructure upgrades in the first nine months of 2025, enhancing reliability and service capacity.
Ameren continues to anticipate earnings growth at a 6% to 8% compound annual rate through 2029, with updated 2025 EPS guidance raised to $4.90-$5.10.
Engagement with data center developers has expanded construction agreements to 3 gigawatts, signaling strong future demand and economic growth.
Electric rates remain competitive, below national and Midwest averages, supporting the company's commitment to customer affordability.

View recap

Air France-KLM SA

AF.PA Q3 2025

Reported: 2025-11-07

Air France-KLM demonstrated resilience in Q3 2025 with stable operating margins at 13.1%, a 3% revenue growth year-over-year, and a solid operating income improvement, despite facing external challenges.

Key takeaways

Revenues increased to EUR 9.2 billion, supported by a 5% rise in passenger traffic, totaling 29.2 million.
Operating income rose by EUR 23 million year-over-year to EUR 1.2 billion, reflecting effective cost management despite rising operational charges.
The loyalty program, Flying Blue, was recognized as the world's best airline loyalty program for the second consecutive year, enhancing customer engagement.
Almost one-third of the fleet is now composed of new generation aircraft, marking an 8-point increase from the previous year, supporting sustainability and efficiency goals.
Strategic network expansions include new destinations in Asia, the Caribbean, and North America, reinforcing market presence and connectivity.

View recap

Aflac Incorporated

AFL Q3 2025

Reported: 2025-11-07

Aflac Incorporated reported solid third-quarter 2025 results, with adjusted earnings per diluted share rising 15.3% year-over-year to $2.49, driven by strong sales performance in both Japan and the U.S.

Key takeaways

Aflac Japan recorded an impressive 11.8% year-over-year sales increase, notably fueled by a 42% surge in cancer insurance sales.
New sales in Aflac U.S. reached $390 million, marking a 2.8% increase from the previous year, maintaining a strong premium persistency of 79%.
Aflac repurchased a record $1 billion in shares and paid $309 million in dividends during the quarter, reinforcing its commitment to shareholder returns.
The company celebrated 43 consecutive years of dividend increases, highlighting its strong financial position and capital management strategy.
Continued emphasis on underwriting discipline and premium persistency is expected to drive further net earned premium growth, supporting the company’s long-term objectives.

View recap

Assured Guaranty Ltd.

AGO Q3 2025

Reported: 2025-11-07

Assured Guaranty Limited reported strong third-quarter results, achieving record highs in adjusted book value and operating income, bolstered by robust activity in the U.S. public finance sector.

Key takeaways

Adjusted operating income rose 17% year-over-year to $6.77 per share; adjusted book value per share reached a record $181.37.
Third quarter premium volume production (PVP) surged to $91 million, up 44% year-over-year, driven by a resurgence in U.S. municipal bond issuance.
Assured Guaranty secured 63% of the total insured U.S. municipal market par sold in the first nine months of 2025, emphasizing its industry leadership.
The company's investment portfolio benefitted from alternative investments, achieving an annualized internal rate of return of approximately 13% year-to-date.
A new $100 million share repurchase authorization reflects continued commitment to enhancing shareholder value.

View recap

a.k.a. Brands Holding Corp.

AKA Q3 2025

Reported: 2025-11-07

No summary provided.

Key takeaways

Successfully opened Princess Polly's 11th store and enhanced its supply chain strategy to improve resilience and flexibility.
Year-to-date net sales increased by 5%, with adjusted EBITDA surpassing $17 million and gross margin expanding by 100 basis points.
Fourth-quarter net sales are tracking positive low single digits, indicating recovery as inventory levels stabilize.
Continuation of a focus on direct-to-consumer channels with trend-driven merchandising and robust digital marketing strategies, particularly on TikTok.
Expansion plans include 8 to 10 additional Princess Polly stores in 2026 and growing wholesale partnerships, particularly with Nordstrom and asos.com.

View recap

Alpha Services and Holdings S.A.

ALPHA.AT Q3 2025

Reported: 2025-11-07

Alpha Bank reported robust financial performance for the first nine months of 2025, achieving EUR 704 million in profits and a 13.9% return on tangible equity, driven by strong net interest income and strategic partnerships.

Key takeaways

Earnings per share reached EUR 0.27, representing 73% of the annual target, with a planned interim cash dividend of EUR 111 million.
The bank’s partnership with UniCredit deepened, as UniCredit increased its stake to approximately 30%, enhancing cross-border operational capabilities and client access.
Continued momentum in fee income from Asset and Wealth Management, along with solid growth in corporate lending, positions Alpha Bank favorably against peers.
EPS is projected to grow by 10% annually beyond 2025, supported by ongoing capital allocation to profitable loan growth and strategic initiatives.

View recap

Amprius Technologies, Inc.

AMPX Q3 2025

Reported: 2025-11-07

Amprius Technologies reported record Q3 2025 revenue of $21.4 million, a 42% sequential increase, driven by strong demand for its innovative silicon anode batteries, particularly in the aviation sector.

Key takeaways

Revenue surged 173% year-over-year, bolstered by over 80 new customers in Q3 alone.
The second-generation SiCore batteries significantly contributed to revenue, with shipments more than quadrupling compared to Q3 2024.
Approximately 75% of Q3 revenue originated from the aviation segment, primarily unmanned aerial systems (UAS).
The company achieved positive gross margins for the second consecutive quarter, enhancing financial performance amidst industry challenges.

View recap

Alpha Metallurgical Resources, Inc.

AMR Q3 2025

Reported: 2025-11-07

Alpha Metallurgical Resources delivered solid Q3 results with adjusted EBITDA of $41.7 million and continued cost discipline, achieving the best cost of coal sales since 2021 at $97.27 per ton, though faced with declining metallurgical coal realizations.

Key takeaways

Adjusted EBITDA declined to $41.7 million from $46.1 million in Q2, maintaining shipment volumes of 3.9 million tons.
Metallurgical segment realizations decreased to a weighted-average of $117.62 per ton, down from $122.84 per ton in Q2.
Cost of coal sales successfully reduced to $97.27 per ton for the second consecutive quarter.
Unrestricted cash totaled $408.5 million, with total liquidity reaching $568.5 million, reflecting effective cash management.
Development production commenced at the Kingston Wildcat mine, targeting a full annual run rate of approximately 1 million tons by 2026.

View recap

Aemetis, Inc.

AMTX Q3 2025

Reported: 2025-11-07

Aemetis reported a robust revenue increase of 13% year-over-year to $59.2 million, driven by strong biodiesel demand in India and improved ethanol margins, positioning the company for future growth.

Key takeaways

Revenues rose to $59.2 million, primarily from biodiesel orders in India and improved ethanol sales pricing.
Operating loss decreased due to higher volumes and reduced SG&A expenses.
Significant capacity increase in dairy renewable natural gas production with a new multi-dairy digester, on track to reach over 500,000 MMBtu by year-end.
$30 million Mechanical Vapor Recompression system expected to enhance ethanol production efficiency and increase cash flow by $32 million annually starting mid-2026.
Anticipation of strong cash flow growth in Q4 due to multiple income streams, including LCFS and Section 45Z credits.

View recap

Artivion Inc. Common Stock

AORT Q3 2025

Reported: 2025-11-07

Artivion delivered robust Q3 2025 results with constant currency revenue growth of 16% and adjusted EBITDA growth of 39%, driven by strong performance from stent grafts and On-X valves.

Key takeaways

Stent graft revenues surged 31% year-over-year, supported by the early adoption of AMDS, positioning it as a key growth driver.
On-X valves achieved a 23% revenue increase, benefiting from market share gains and the unique clinical advantages of the product.
The recent CMS reimbursement update for complex aortic procedures is expected to enhance the economic proposition of AMDS, further driving adoption.
Investment in expanded operational capacity in Austin, Texas indicates proactive measures to support anticipated growth in the On-X business.
Artivion maintains a strong pipeline of clinical evidence and promising early commercial traction across its product portfolio.

View recap

Air Products and Chemicals, Inc.

APD Q4 2025

Reported: 2025-11-07

Air Products delivered solid fiscal Q4 2025 results with earnings per share of $12.03, aligning with strategic goals amid ongoing macroeconomic challenges and a commitment to capital discipline.

Key takeaways

Achieved an operating income margin of 23.7% and a return on capital of 10.1%, meeting full-year guidance.
Announced $1.6 billion returned to shareholders, marking the 43rd consecutive year of dividend increases.
Targeting high single-digit EPS growth in fiscal 2026 despite anticipated helium headwinds and a cautious macroeconomic outlook.
Implementing significant cost-saving measures, including a headcount reduction of 3,600, expected to yield $250 million in annual savings.
Project NEOM is approximately 90% complete, with full ammonia production expected in 2027, supporting future growth initiatives.

View recap

AppLovin Corporation

APP Q3 2025

Reported: 2025-11-07

AppLovin delivered a robust Q3 with revenues of $1.405 billion, up 68% year-over-year, bolstered by strong performance in gaming advertising and a successful early launch of its self-service platform.

Key takeaways

Adjusted EBITDA reached $1.158 billion, reflecting a margin of 82%, with free cash flow up 92% year-over-year to $1.049 billion.
Significant share repurchase activity, with 1.3 million shares bought for $571 million and a new $3.2 billion authorization announced.
Anticipated Q4 revenue guidance of $1.570 billion to $1.6 billion, indicating 12% to 14% sequential growth, backed by strong execution and operational momentum.
Early traction from the self-service platform shows promising 50% week-over-week spend growth among new advertisers.

View recap

Appian Corporation

APPN Q3 2025

Reported: 2025-11-07

Appian delivered strong financial performance in Q3 2025, with total revenue growing 21% to $187 million, driven by solid increases in both cloud subscriptions and overall subscription revenues.

Key takeaways

Cloud subscriptions revenue rose 21% to $113.6 million, highlighting the resilience of Appian's core business.
The weighted Rule of 40 score improved to 39, reflecting enhanced go-to-market productivity and operational efficiency.
More than 25% of customers are now utilizing Appian AI solutions, showcasing strong market demand for integrated AI and process automation capabilities.
Appian's AI-driven automation is delivering significant ROI for customers, with reported enhancements in processing times across various business functions.
The company continues to be recognized as a leader in process orchestration and automation technologies, further solidifying its competitive position in the market.

View recap

Arhaus Inc. Class A Common Stock

ARHS Q3 2025

Reported: 2025-11-07

Arhaus delivered a robust third quarter in 2025, achieving record net revenue of $345 million and demonstrating strong brand demand with a 4.1% comparable growth rate.

Key takeaways

Net revenue increased 8% year-over-year, marking the highest third-quarter revenue in company history.
The Fall 2025 Collection was the most successful launch in Arhaus history, indicating strong consumer engagement and design leadership.
Record demand was recorded for September and for custom upholstery, driven by the successful introduction of innovative designs and a well-performing in-home design program.
New showroom openings, including a flagship location in Pasadena, California, are expected to enhance brand visibility and customer engagement.
Vertically integrated operations continue to provide Arhaus with quality control and supply chain resilience, particularly in upholstery production.

View recap

Atmos Energy Corporation

ATO Q4 2025

Reported: 2025-11-07

Atmos Energy delivered robust fiscal 2025 results, achieving a diluted EPS of $7.46—marking the 23rd consecutive year of growth—while also expanding its customer base and capital investments significantly.

Key takeaways

Added approximately 57,000 residential customers and nearly 3,200 commercial customers during fiscal '25, driving natural gas demand.
Consolidated capital spending rose to $3.6 billion, with 87% focused on enhancing safety and reliability of the gas distribution system.
Successful implementation of Texas House Bill 4384 enabled quicker capital recovery, allowing recovery of over 95% of spending within 6 months.
EPS growth target of 6% to 8% expected for fiscal '26, with plans to align dividend growth with this performance.

View recap

AvePoint Inc. Class A Common Stock

AVPT Q3 2025

Reported: 2025-11-07

AvePoint, Inc. delivered a strong performance in Q3 2025, outperforming revenue and non-GAAP operating income guidance as the demand for robust governance solutions in the AI landscape continues to rise.

Key takeaways

Revenues exceeded guidance, highlighting strong customer adoption of AvePoint's governance platform amid growing AI concerns.
86% of surveyed companies delayed AI rollouts by up to 12 months due to security and governance issues, underscoring market demand for AvePoint's solutions.
Introduction of the enhanced AvePoint Confidence Platform offers improved visibility and lifecycle control for agentic AI, addressing critical compliance and data protection needs.
The launch of the operational efficiency Command Center allows clients to measure governance impact, elevating oversight to the Board level.
Strategic partnerships with major tech companies enhance governance integration across diverse SaaS and cloud environments, bolstering AvePoint's market position.

View recap

Barrett Business Services, Inc.

BBSI Q3 2025

Reported: 2025-11-07

BBSI reported strong Q3 2025 results, highlighted by an 8.6% increase in gross billings driven by record worksite employee additions, despite macroeconomic challenges impacting client hiring.

Key takeaways

Gross billings rose to $2.32 billion, an 8.6% year-over-year increase.
Added a record 10,400 worksite employees from new clients, contributing to a 6.1% total growth.
Staffing revenues declined 10% to $19 million due to client reluctance amid economic uncertainty.
Strong client retention maintained a high Net Promoter Score in the high 60s for three consecutive years.
Continued expansion in new markets with grand openings in Chicago and Dallas, and future plans for Nashville in January.

View recap

Black Hills Corporation

BKH Q3 2025

Reported: 2025-11-07

Black Hills Corp. reported strong Q3 2025 results, reaffirming its earnings guidance with a solid adjusted EPS of $0.45, reflecting strategic progress in regulatory and capital initiatives.

Key takeaways

Adjusted EPS increased to $0.45 from $0.35 year-over-year, aided by new rates and rider recoveries.
Concluded seven rate reviews since 2024, reinforcing regulatory strategy and customer growth.
Advancing a $1 billion capital plan, including completion of the Ready Wyoming transmission expansion by year-end.
Merger with NorthWestern Energy is progressing, expected to enhance competitiveness and unlock additional value for stakeholders.
Confidently reaffirming 2025 earnings guidance of $4 to $4.20 per share, aiming for upper-range EPS growth through 2026.

View recap

BlackSky Technology Inc.

BKSY Q3 2025

Reported: 2025-11-07

BlackSky Technologies reported strong third-quarter performance, highlighted by over $60 million in new international contracts and significant progress in deploying its Gen-3 satellite capabilities, positioning the company well for future growth.

Key takeaways

Secured more than $60 million in new contracts, primarily from international customers, enhancing revenue diversification.
Awarded a $30 million contract to integrate Gen-3 ISR services for a strategic international defense client, underscoring demand for sovereign space capabilities.
International revenue now accounts for approximately 50% of total sales, with over 90% of backlog related to Gen-3 capabilities.
Cash balance increased by over 50% year-over-year, providing a stronger liquidity position with total cash exceeding $200 million.
Anticipating a robust fourth quarter as momentum from international contracts continues to build into 2026.

View recap

BK Technologies Corporation

BKTI Q3 2025

Reported: 2025-11-07

BK Technologies reported robust third-quarter performance, achieving a 21% increase in revenue to $24.4 million, alongside significant gross margin improvement to 49.9%.

Key takeaways

Net income surged 46% to $3.4 million, equating to $0.87 per diluted share; non-GAAP adjusted EPS reached $1.27.
Strong demand for the BKR 9000 multiband radio contributed to sustained revenue growth and a favorable sales mix.
Cash and cash equivalents rose to $21.5 million with no debt, providing financial flexibility for strategic investments.
Operating income increased to $4.8 million, driving an operating margin of 19.8%, up from 12.9% year-over-year.

View recap

Bloomin' Brands, Inc.

BLMN Q3 2025

Reported: 2025-11-07

Bloomin' Brands delivered solid operational improvements in Q3 2025, with management emphasizing a focused turnaround strategy centered on enhancing the guest experience and simplifying restaurant operations.

Key takeaways

Implemented operational changes, including menu simplifications and improved brand positioning, leading to enhanced guest satisfaction metrics.
Successfully refranchised restaurants in Brazil, streamlining corporate structure and reducing operational complexity.
Increased profitability through the introduction of value-driven offers in casual dining brands, boosting customer retention and table turnover.
Continued commitment to test-and-learn culture, with expanded testing of menu innovations and service enhancements across Outback restaurants.
Strong leadership team established, with significant operational experience, to drive the turnaround efforts across the brand portfolio.

View recap

Blink Charging Co.

BLNK Q3 2025

Reported: 2025-11-07

Blink Charging demonstrated strong operational progress in Q3 2025, achieving a 7.3% revenue increase year-over-year and significant improvements in gross margins and cash burn efficiency.

Key takeaways

Total revenue reached $27 million, with service revenue hitting a record $11.9 million, up 36% year-over-year.
Gross margins improved to 35.8%, driven by a focus on higher-margin products and service revenues.
Cash burn was reduced by 87% sequentially to $2.2 million, marking the lowest level in over three years.
The company is shifting from in-house manufacturing to third-party partnerships, enhancing focus on service revenue and operational efficiency.
Blink's transformation efforts have resulted in the elimination of $13 million in annualized expenses, reinforcing a path to profitability.

View recap

Borr Drilling Limited

BORR Q3 2025

Reported: 2025-11-07

Borr Drilling Limited reported a robust Q3 2025, with a revenue increase of $9.4 million quarter-over-quarter and adjusted EBITDA growth to $135.6 million, while maintaining high utilization rates across its fleet.

Key takeaways

Revenue growth driven by increased day rates and bareboat chartering, with total operating revenues at $158.3 million.
Adjusted EBITDA margin remains strong at 48.9%, reflecting high operational efficiency.
Significant liquidity position with $461.8 million available, including $227.8 million in free cash.
Secured three contract extensions in Mexico, enhancing visibility into 2026 and beyond.
Optimistic outlook for Q4 2025 despite near-term transition impacts, with full-year adjusted EBITDA projected between $455 million and $470 million.

View recap

Bowman Consulting Group Ltd. Common Stock

BWMN Q3 2025

Reported: 2025-11-07

Bowman Consulting achieved a significant milestone with a $500 million annualized gross revenue rate for Q3 2025, driven by 11% year-over-year net revenue growth and an 8% increase in adjusted EBITDA.

Key takeaways

Net revenue reached $112 million, supported by over 20% growth in transportation and power utility markets.
GAAP net income surged to $6.6 million, compared to just $800,000 in the same quarter last year.
Record backlog of $448 million grew nearly 18% year-over-year, indicating strong demand across key sectors.
Adjusted EPS doubled to $0.61, reflecting improved operational efficiency and growth in billed revenue.
Total overhead decreased as a percentage of net revenue, enhancing profit margins and capital efficiency.

View recap

Commerzbank AG

CBK.DE Q3 2025

Reported: 2025-11-07

Commerzbank AG reported the best nine-month operating result in its history, driven by strong growth in corporate loans and fee income, positioning the bank favorably for continued momentum into 2026.

Key takeaways

Achieved 13% loan growth in Corporate Clients and an 11% increase in total revenues, underscoring robust client relationships.
Cost-income ratio improved to 56%, aligning with strategic goals towards enhanced efficiency.
Return on tangible equity reached 10% (excluding restructuring charges), establishing a new baseline for future growth.
Successful implementation of an employee share program aimed at enhancing shareholder value and engagement.
Strong potential from the German stimulus package expected to boost economic growth and banking performance in the coming years.

View recap

CareCloud Inc. Common Stock

CCLD Q3 2025

Reported: 2025-11-07

CareCloud, Inc. reported a robust 9% year-over-year revenue increase to $31.1 million in Q3 2025, successfully executing two strategic acquisitions that expand its market presence and capabilities.

Key takeaways

Revised full-year revenue guidance raised to $117-$119 million, up from $111-$114 million, underpinned by strong operational momentum.
Adjusted EBITDA increased 13% year-over-year to $7.7 million, highlighting effective cost management and operational leverage.
Completion of the Medsphere acquisition enhances CareCloud's offerings in the inpatient market, positioning the company for significant growth across the healthcare continuum.
The acquisition of Map App strengthens CareCloud's analytics and benchmarking capabilities, further solidifying its value proposition in the hospital sector.
No dilution to common shareholders during acquisitions, demonstrating disciplined capital allocation strategies and improved cash flow management.

View recap

Chimera Investment Corporation

CIM Q3 2025

Reported: 2025-11-07

Chimera Investment Corporation reported a GAAP net loss of $22 million for Q3 2025, yet successfully closed the acquisition of HomeXpress, positioning itself for future growth and revenue diversification.

Key takeaways

HomeXpress acquisition closed for $267 million, expected to significantly enhance earnings and diversification.
Year-to-date economic return on GAAP book value stood at 8.3%, despite a negative return of 1.4% in Q3.
HomeXpress originated $2.4 billion in loans through September, with projected Q4 originations of $1 billion yielding $13 million to $15 million in after-tax earnings.
Management anticipates long-term economic benefits from the integration of HomeXpress and Palisades, enhancing both operational efficiency and market reach.

View recap

Clarus Corporation

CLAR Q3 2025

Reported: 2025-11-07

Clarus Corporation reported a modest 3% increase in net sales to $69.3 million for Q3 2025, bolstered by strong demand in the Outdoor segment and improvements in operational efficiency, despite ongoing macroeconomic challenges.

Key takeaways

Adjusted EBITDA grew by 15% year-over-year, reflecting improvements in organizational structure and product focus.
The revamped Black Diamond apparel line achieved a remarkable 29% sales growth, indicating positive market reception.
Operating expenses (SG&A) decreased by $600,000 compared to the previous year, contributing to enhanced profitability.
Despite tariff pressures and FX losses impacting margins, strategic pricing adjustments are planned to restore profitability alongside inventory rationalization.

View recap

ConocoPhillips

COP Q3 2025

Reported: 2025-11-07

ConocoPhillips reported strong third-quarter performance, exceeding production guidance and raising its full-year outlook while enhancing shareholder returns, including an 8% dividend increase.

Key takeaways

Produced 2.4 million barrels of oil equivalent per day, surpassing guidance and establishing a solid foundation for 2026.
Adjusted earnings of $1.61 per share and generated $5.4 billion in cash from operations, with total shareholder returns reaching $7 billion year-to-date.
Capital expenditures decreased to $2.9 billion as the company transitions past peak investment cycles, while full-year production guidance was raised to 2.375 million barrels per day.
Project capital estimate for Willow increased to $8.5–9 billion due to inflation, but project timeline remains on track for first oil in early 2029.
Strategic asset sales program progressing well, with $3 billion completed toward a $5 billion target, indicating strong portfolio management and cash flow enhancement.

View recap

Corpay, Inc.

CPAY Q3 2025

Reported: 2025-11-07

Corpay reported robust Q3 2025 results with 14% revenue and cash EPS growth, driven by strong performance in both the Vehicle and Corporate Payments segments.

Key takeaways

Q3 organic revenue growth reached 11%, with Corporate Payments up 17% despite a slight flow compression.
Retention improved to 92.4%, and new bookings surged 24%, indicating strong client engagement.
Q4 revenue guidance raised to $1.235 billion, with an expected cash EPS of $5.90, fueled by recent acquisitions and strong ongoing trends.
The company projects 2026 revenue growth of 9% to 11%, underpinned by favorable macroeconomic conditions and estimated incremental accretion from recent M&A transactions.

View recap

RH

CRH Q3 2025

Reported: 2025-11-07

CRH achieved a record third quarter in 2025, raising its adjusted EBITDA guidance for the year, driven by strong market demand, strategic acquisitions, and operational efficiency.

Key takeaways

Total revenues reached $11.1 billion, up 5% year-over-year, with adjusted EBITDA of $2.7 billion representing a 10% increase.
A 100 basis point expansion in adjusted EBITDA margin reflects ongoing focus on operational performance.
Year-to-date, CRH has invested $3.5 billion in 27 acquisitions, indicating robust pipeline and commitment to future growth.
Positive market trends in infrastructure, particularly in transportation and water sectors, position the company for substantial above-market growth.
Full year adjusted EBITDA is now forecasted between $7.6 billion and $7.7 billion, supporting a continued trajectory of success.

View recap

Cresco Labs Inc.

CRLBF Q3 2025

Reported: 2025-11-07

Cresco Labs reported a modest revenue growth of 1% to $165 million in Q3 2025 while making strategic moves to strengthen the balance sheet and focus on core markets for sustainable growth.

Key takeaways

Adjusted EBITDA reached $40 million, reflecting disciplined execution and a focus on cash-generating operations.
Completed debt refinancing, enhancing financial flexibility and positioning for future investments and M&A opportunities.
Exited California operations, reducing liabilities and organizational complexity to concentrate on more profitable ventures.
Maintained #1 retail share in Ohio with successful new dispensary openings planned for early 2026, while preparing to enter Kentucky's medical market.
Set to launch flagship Cresco branded products in Germany, marking the company's entry into the European Union market.

View recap

Carriage Services, Inc.

CSV Q3 2025

Reported: 2025-11-07

Carriage Services delivered solid third-quarter results, with total operating revenue increasing 5.2% year-over-year to $101.3 million, bolstered by a significant 21.4% rise in preneed cemetery sales and strong growth in general agency commission revenue.

Key takeaways

Preneed cemetery sales surged 21.4% year-over-year, reflecting renewed momentum and robust demand.
Adjusted consolidated EBITDA rose to $33 million, marking a 7.3% increase, with margins expanding by 160 basis points to 32.1%.
Adjusted diluted earnings per share increased 17.2% to $0.75 from $0.64 in the prior year, emphasizing effective operational strategies and financial management.
The company is set to enhance sales capabilities through the launch of Sales Edge 2.0 and Titan, an AI-powered sales agent, aimed at further accelerating growth in preneed sales.

View recap

CoreCivic, Inc.

CXW Q3 2025

Reported: 2025-11-07

CoreCivic reported strong contract activations in Q3 2025, projecting significant earnings growth driven by new detention facility contracts, although initial start-up costs are expected to impact Q4 performance.

Key takeaways

Secured four new contracts with total expected annual revenue of approximately $320 million, enhancing 2026 revenue projections.
Full-year 2025 financial guidance indicates an anticipated annual revenue run rate of $2.5 billion and EBITDA exceeding $450 million once facilities reach stabilized occupancy.
ICE detention populations reached historical highs, suggesting potential for increased demand from government partners.
Ongoing share repurchase program saw $121 million in shares bought back year-to-date, indicating strong management confidence in stock valuation.
Company maintains approximately 24,000 available beds, poised to accommodate additional government demand.

View recap

Box, Inc.

DBX Q3 2025

Reported: 2025-11-07

Dropbox reported strong Q3 2025 results, with revenue surpassing guidance due to improved retention in its product offerings, particularly the newly enhanced Dash platform.

Key takeaways

Constant currency revenue exceeded guidance, driven by robust retention rates across individual and self-serve plans.
Non-GAAP operating margin improved year-over-year, reflecting enhanced operational efficiency.
The Dash platform saw significant upgrades, including a 75% reduction in search latency and new multimodal capabilities, enhancing overall user experience.
Early engagement metrics for Dash indicate strong adoption, with 60% of weekly active users utilizing the tool at least two days per week.
Dropbox is rolling out native Dash integration within its FSS app, broadening access to its SMB customer base and driving trial conversions.

View recap

Definitive Healthcare Corp. Class A Common Stock

DH Q3 2025

Reported: 2025-11-07

Definitive Healthcare reported Q3 2025 results with $60 million in revenue, slightly down from last year but exceeding guidance, driven by improved operational efficiency and customer retention rates.

Key takeaways

Adjusted EBITDA reached $18.9 million, a margin of 32%, surpassing the high end of guidance by $2 million.
Customer count remained stable at 2,400, with a notable increase of 10 enterprise customers, the highest level since Q3 last year.
Continued focus on differentiated data led to significant wins in customer engagements, solidifying competitive advantages in the market.
Year-over-year retention rates improved, reflecting positive trends in customer satisfaction and operational execution.

View recap

Dine Brands Global, Inc.

DIN Q3 2025

Reported: 2025-11-07

Dine Brands' Q3 2025 results reflect resilience amidst a competitive landscape, with Applebee's achieving positive comp sales while IHOP faced a slight downturn, driven by strategic menu innovations and robust marketing efforts.

Key takeaways

Applebee's reported a 3.1% increase in comparable sales and maintained positive comp traffic for the second consecutive quarter.
IHOP's comparable sales declined by 1.5%, although value offerings remained a focus for the brand.
Adjusted EBITDA decreased to $49 million from $61.9 million year-over-year, highlighting the industry's pressures.
The introduction of targeted menu items, like Chicken Parmesan Fettuccine and the Ultimate Trio appetizer, significantly contributed to sales and guest engagement.
Enhanced marketing efforts yielded a 266% increase in social media engagement, underscoring the brand's commitment to modernizing the guest experience.

View recap

Krispy Kreme Inc. Common Stock

DNUT Q3 2025

Reported: 2025-11-07

Krispy Kreme's Q3 2025 results show promising progress in its turnaround strategy, marked by a focus on refranchising, cost efficiency, and strategic partnerships that are enhancing profitability and expanding market reach.

Key takeaways

Continued refranchising efforts expected to enhance profitability and reduce net debt while exploring international growth opportunities.
Operational efficiencies and cost reductions are driving margin expansion, especially through optimized production and logistics.
Addition of approximately 1,000 profitable doors with strategic partners, supporting strong sales growth in high-margin segments like Target and Walmart.
Digital sales in the U.S. rose 17% year-over-year, reflecting effective marketing and engagement strategies.

View recap

DigitalOcean Holdings, Inc.

DOCN Q3 2025

Reported: 2025-11-07

DigitalOcean delivered a robust third quarter, outperforming expectations with 16% revenue growth and record organic ARR, bolstered by strong demand from AI-native and digital enterprise customers.

Key takeaways

Revenue reached $230 million, the highest growth rate since Q3 2023, with $44 million in organic incremental ARR.
Adjusted EBITDA and non-GAAP EPS exceeded guidance, achieving a trailing 12-month adjusted free cash flow margin of 21%.
Revenue from customers with over $1 million in annual run rate grew 72% year-over-year, highlighting increased retention and spending.
The company's expanding AI infrastructure is attracting significant traction among major AI-native companies, enhancing future growth potential.
DigitalOcean's balance sheet was strengthened through strategic equipment leasing and the repurchase of its 2026 convertible debt.

View recap

electroCore, Inc.

ECOR Q3 2025

Reported: 2025-11-07

electroCore's Q3 2025 results reflect a strategic pivot aimed at accelerating growth through key investments and acquisitions, despite a temporary delay in profitability.

Key takeaways

Delivered robust revenue growth in the VA channel, secured a new 5-year contract, and expanded sales capabilities.
Acquired NeuroMetrix's Quell portfolio, enhancing product offerings and diversifying revenue streams with a new FDA-cleared device for fibromyalgia.
Initiated targeted investments in technology and personnel to support growth in both medical and wellness divisions, positioning the company for future success.

View recap

Flex Ltd.

EFX.TO Q3 2025

Reported: 2025-11-07

Enerflex delivered robust third-quarter results, driven by strong performance in its energy infrastructure and aftermarket services divisions, alongside strategic expansions in North America and international markets.

Key takeaways

Engineered Systems hit a new revenue record, bolstered by a $1.1 billion backlog and a book-to-bill ratio of 0.9x, indicating solid demand.
Increased contract compression fleet utilization to 94%, with plans to expand to 485,000 horsepower by 2026 amid rising natural gas production in the Permian.
Secured a significant contract for a 200 mmcfd cryogenic gas processing facility in the U.S. and achieved rapid project completions across international projects, including Oman and Argentina.
Declared a dividend increase as part of disciplined capital allocation strategy, reflecting confidence in financial strength and growth prospects moving forward.

View recap

Eos Energy Enterprises, Inc.

EOSE Q3 2025

Reported: 2025-11-07

Eos Energy achieved record third-quarter revenue, driven by increased order bookings and strategic partnerships, positioning the company for sustainable growth and profitability.

Key takeaways

Delivered the highest revenue quarter in company history, signaling strong operational performance and demand.
Secured significant customer cash inflows totaling $43 million in Q4, demonstrating improved financial stability.
Established a strategic agreement with Talen Energy, enhancing operational capabilities and market presence.
Commenced plans for a new optimized factory and software hub in Pittsburgh to bolster production efficiency and innovation.
Continued investment in human capital with low turnover rates, attracting top talent to support growth initiatives.

View recap

Eversource Energy

ES Q3 2025

Reported: 2025-11-07

Eversource Energy's Q3 2025 results demonstrate strong operational execution and strategic progress, positioning the company favorably among its peers with a year-to-date top performance in share price.

Key takeaways

Achieved a top decile reliability performance and a significant improvement in the funds from operations (FFO) to debt ratio due to favorable regulatory outcomes.
On track to invest nearly $5 billion in transmission and distribution infrastructure this year, enhancing the company’s operational strength.
Weather-normalized load growth of 2% year-to-date, with summer peak demand reaching over 12 gigawatts, indicating robust growth driven by electrification and decarbonization initiatives.
Progress on significant projects: construction of the Revolution Wind project is nearly complete, with back-feed energization anticipated by November.
Strategic collaboration with the new PURA commissioners aims to foster balanced regulatory outcomes beneficial for stakeholders and customers.

View recap

Esperion Therapeutics, Inc.

ESPR Q3 2025

Reported: 2025-11-07

Esperion Therapeutics reported a strong Q3 2025 with a 69% year-over-year revenue increase, leveraging strategic investments and marketing efforts to drive prescription growth amid heightened recognition of its bempedoic acid products.

Key takeaways

Total revenue reached $87.3 million, driven by a 31% year-over-year growth in U.S. net product revenue.
The company secured agreements with four generic manufacturers to protect its NEXLETOL franchise through April 2040, enhancing long-term value.
Increased prescriber engagement and strategic marketing aimed at statin-intolerant patients contributed to improved brand awareness and prescription growth.
The introduction of bempedoic acid products in ESC/EAS guidelines marks a significant clinical validation, with expectations for U.S. guideline inclusion in early 2026.
An 87% average approval rate for Medicare coverage reflects successful efforts in enhancing patient access.

View recap

Evaxion Biotech A/S

EVAX Q3 2025

Reported: 2025-11-07

Evaxion reported a strong Q3 2025, highlighted by a transformative deal with MSD, marking a significant milestone in their AI-driven vaccine development and extending their cash runway into 2027.

Key takeaways

MSD exercised their option on the AI-discovered vaccine candidate EVX-B3, generating a $7.5 million exercise fee that enhances financial stability.
Two-year clinical efficacy data for EVX-01 showed a promising 75% objective overall response, generating sustained T cell activity across patients.
Introduction of EVX-04, targeting acute myeloid leukemia, expands Evaxion’s pipeline, underscoring their commitment to precision cancer vaccines.
Investment in an upgraded AI-Immunology platform with an automated vaccine design module optimizes development processes and cost efficiency.
Cash runway extended to the second half of 2027, ensuring ongoing R&D and business development initiatives.

View recap

Evergy, Inc.

EVRG Q3 2025

Reported: 2025-11-07

Evergy's third quarter 2025 results show slight year-over-year adjusted earnings growth, driven by recovered regulated investments despite adverse weather impacts. The company has a strong outlook bolstered by significant demand growth opportunities.

Key takeaways

Adjusted EPS for Q3 2025 is $2.03, up from $2.02 a year earlier, while year-to-date EPS has decreased slightly to $3.41 from $3.46.
The company narrowed its 2025 adjusted EPS guidance to $3.92-$4.02, primarily due to weather-related challenges that impacted earnings by $0.13 per share.
Evergy announced a 4% increase in its quarterly dividend, reflecting confidence in its updated growth outlook and commitment to a 60%-70% payout ratio.
Strong interest from large customers is evident with a robust economic development pipeline, including a transformative 4-6 gigawatt opportunity projected to enhance regional growth and job creation.
Operational performance remains strong, with generation availability and grid reliability both exceeding target metrics through September.

View recap

Expensify Inc. Class A Common Stock

EXFY Q3 2025

Reported: 2025-11-07

Expensify delivered robust performance in Q3 2025 with revenue of $35.1 million and significant growth in travel bookings, supporting strategic new customer wins and product advances.

Key takeaways

Revenue increased to $35.1 million with average paid members rising to 642,000.
Travel bookings soared 95% since Q1, underscoring strong demand for Expensify Travel.
Non-GAAP net income reached $4.3 million, with adjusted EBITDA at $6.5 million.
Completed significant migration to New Expensify, targeting 90% feature parity with Classic.
Initiated stock repurchase program totaling $3 million to enhance shareholder value.

View recap

Expedia Group, Inc.

EXPE Q3 2025

Reported: 2025-11-07

Expedia Group's Q3 2025 results surpassed expectations with a 12% increase in bookings and a 9% rise in revenue, driven by strong demand and disciplined execution across its strategic priorities.

Key takeaways

Booked room nights increased 11%, with significant growth in B2B bookings, up 26%, marking 17 consecutive quarters of double-digit growth.
Positive shifts in the U.S. market and high double-digit growth in EMEA and Asia demonstrate strong consumer demand.
Continued enhancements in traveler experience through AI integration and improved loyalty programs resulted in double-digit growth in vacation rentals.
The company is raising its full-year guidance based on current trends and robust performance across its brands, particularly Expedia and Vrbo.
Strong advertising performance, with a record number of active partners, shows effective monetization strategies and AI-driven improvements in targeting.

View recap

FI

Simplify Macro Strategy ETF

FIG Q3 2025

Reported: 2025-11-07

Figma achieved a record Q3 2025 with $274 million in revenue, marking a 38% year-over-year increase and surpassing guidance, while the company accelerated its product innovation and AI investment strategy.

Key takeaways

Revenue exceeded $1 billion in annual revenue run rate, with a record sequential net revenue increase.
Net dollar retention rose to 131%, reflecting increased adoption of new products.
Non-GAAP operating margin stood at 12% with adjusted free cash flow margin at 18%, despite significant investments in talent and AI.
Launched over 50 new features in Q3 to enhance customer experience and drive product velocity.
Strategic focus on AI integration and platform interoperability is expanding Figma's reach across diverse customer teams and industries.

View recap

Leonardo S.p.a.

FINMY Q3 2025

Reported: 2025-11-07

Leonardo reported strong third-quarter results for 2025, with new orders up 24.3% and revenues increasing by 12.4%, reflecting robust performance across all divisions.

Key takeaways

New orders reached EUR 18 billion year-over-year, driven by solid performances in electronics, naval, and defense sectors.
Revenue rose to EUR 13.4 billion, with EBITDA growing 22.7% to EUR 945 million.
Net debt decreased by 25.9%, indicating improved financial health and operational efficiency.
Prominent contracts, including a EUR 2 billion deal with the Kuwait Air Force, significantly contributed to strong sales.
The company is adapting well to market dynamics with a favorable outlook on future orders and strategic partnerships.

View recap

Five9, Inc.

FIVN Q3 2025

Reported: 2025-11-07

Five9 reported a strong Q3, driven by a robust 80% year-over-year growth in enterprise AI bookings and a significant increase in both profitability and cash flow.

Key takeaways

Subscription revenue rose 10% year-over-year, with enterprise AI revenue growing 41%.
Adjusted EBITDA margin increased to 25%, marking a 37% year-over-year growth.
Record free cash flow grew 84% year-over-year, achieving a margin of 13%.
Five9's strategic positioning in the AI-powered customer experience (CX) market is strengthened by a rich data advantage and innovative AI integration capabilities.
Recognition as a leader in both Gartner's 2025 Magic Quadrant and IDC's inaugural MarketScape underscores Five9's competitive edge and industry leadership.

View recap

Flowers Foods, Inc.

FLO Q3 2025

Reported: 2025-11-07

Flowers Foods demonstrated resilient performance in Q3 2025, strategically aligning its portfolio amidst category pressures, particularly in the bread sector, while continuing to invest in innovation.

Key takeaways

Despite ongoing challenges in the bread category due to economic factors, early signs of stabilization are emerging, with expectations for improved demand going into 2026.
The company is committed to long-term consumer-focused investments, even as innovation pressures short-term margins.
Successful integration of Simple Mills is yielding positive results, with collaborative efforts driving growth and fostering innovation for future products.
Management expressed gratitude for the contributions of retiring CFO Steve Kinsey, highlighting the leadership stability as a factor for continued progress.
The branded retail business outperformed expectations, while foodservice segments faced headwinds typical in the current economic climate.

View recap

Funko, Inc.

FNKO Q3 2025

Reported: 2025-11-07

Funko's third quarter results for 2025 reveal strong operational momentum, driven by a significant brand presence and renewed licensing agreements, positioning the company for future growth.

Key takeaways

Achieved milestone of 1 billion units sold, emphasizing robust consumer demand.
Active fan loyalty program membership grew by 27% year-to-date, highlighting increased customer engagement.
Secured multiyear licensing renewals with major partners, including Disney and Warner Bros, strengthening the company’s competitive advantage.
The new "Make Culture POP!" strategy focuses on expanding product categories and enhancing speed to market for new trends.
Diversified retail presence with over 1,400 global partners, ensuring broad market reach.

View recap

Fresenius SE & Co. KGaA

FRE.DE Q3 2025

Reported: 2025-11-07

Fresenius reported a robust third quarter, with a significant EBIT growth guidance upgrade from 3-7% to 4-8%, supported by a strong performance in its Kabi and Helios segments.

Key takeaways

Core EPS surged by 14%, highlighting strong bottom-line performance driven by margin expansion and top-line growth.
Kabi achieved an impressive 16.7% EBIT margin, bolstered by newly launched products and strong progress in IV generics and biosimilars.
The Helios division maintained solid EBIT margins, showcasing resilience amid macroeconomic challenges.
Fresenius launched three new products focused on high-energy and protein needs in Q3, enhancing its MedTech portfolio.
The company returned to its self-imposed cash flow target corridor, reflecting disciplined financial management.

View recap

JFrog Ltd.

FROG Q3 2025

Reported: 2025-11-07

JFrog delivered a robust Q3 2025 performance with total revenue of $136.9 million, reflecting a 26% year-over-year growth and a strong commitment to cloud and security solutions.

Key takeaways

Cloud revenue increased to $63.4 million, achieving 50% growth year-over-year, driven by rising usage of AI-generated artifacts and software packages.
The number of enterprise customers grossing over $1 million annually grew by 54% year-over-year, now totaling 71 clients.
Net dollar retention stood at 118% for the trailing four quarters, showcasing continued expansion and customer loyalty in cloud adoption and security offerings.

View recap

FRP Holdings, Inc.

FRPH Q3 2025

Reported: 2025-11-07

FRP Holdings reported a substantial decline in net income for Q3 2025, primarily impacted by acquisition-related expenses; however, adjusted net income improved, reflecting resilient operations amidst strategic developments.

Key takeaways

Net income decreased 51% year-over-year to $700,000, largely due to $1.3 million in one-time acquisition expenses from Altman Logistics.
Adjusted net income, excluding these expenses, increased by 21%, indicating stronger operational performance.
The pro rata share of NOI fell 16% to $9.5 million, though adjusted NOI rose slightly, demonstrating resilience amidst significant royalty impacts.
Occupancy challenges persist in the Commercial and Industrial segment, with a 24% decline, stressing the need for lease and occupancy improvements.
FRP's development pipeline remains robust, with key projects scheduled for completion by 2026, enhancing long-term growth prospects.

View recap

Fortuna Silver Mines Inc.

FSM Q3 2025

Reported: 2025-11-07

Fortuna Mining Corp. delivered robust Q3 2025 results, marked by significant operational achievements and a strong financial performance, including an attributable net income of $123.6 million.

Key takeaways

Achieved a gold price of $3,467 per ounce, contributing to a $123.6 million attributable net income and strong free cash flow of $73 million.
Secured a solid liquidity position with $588 million in cash and $266 million in net cash, enabling future growth investments.
Advanced growth projects like Diamba Sud in Senegal and Séguéla in Côte d'Ivoire, which are expected to substantially increase annual gold production.
Maintained all-in sustaining costs within guidance, with Lindero trending lower and Séguéla impacted by capital investment and higher royalty payments.
Strong focus on safety, achieving 318 days without a lost time injury and an improved total recordable injury frequency rate of 0.86.

View recap

Fortinet, Inc.

FTNT Q3 2025

Reported: 2025-11-07

Fortinet reported strong third-quarter 2025 results, with total billings growing 14% year-over-year to $1.81 billion, driven by robust demand across its cybersecurity solutions, particularly in Unified SASE and SecOps.

Key takeaways

Unified SASE billings surged 19%, with FortiSASE achieving over 100% growth, positioning Fortinet as a SASE market leader.
Total revenue rose 14% to $1.72 billion, reflecting strong sales performance globally, particularly in EMEA and APAC.
The number of large enterprise deals exceeding $1 million climbed by 26%, highlighting Fortinet's expanding footprint among larger clients.
SecOps billing increased 33%, fueled by growing adoption of AI-driven security solutions as part of its comprehensive cybersecurity portfolio.
Fortinet's operational technology solutions also saw more than 30% billing growth, showcasing its strength in critical infrastructure security.

View recap

Genpact Limited

G Q3 2025

Reported: 2025-11-07

Genpact Limited delivered robust Q3 2025 results, with a 7% year-over-year revenue increase to $1.291 billion, driven by the accelerated growth of Advanced Technology Solutions, which surged 20%. The company also reported significant adjusted EPS growth of 14% year-over-year.

Key takeaways

Advanced Technology Solutions, which now represents over 50% of revenue growth, reflects strong momentum with five consecutive quarters of accelerating growth.
Adjusted operating income margin expanded to 17.7%, and gross margin improved to 36.4%, indicating healthy profitability amid strategic investments.
The launch of new innovative products such as AI Maestro and dedicated agentic suites enhances Genpact's competitive position and market share potential.
Year-to-date, over 30% of awarded agentic contract value has come from new clients, showcasing successful client acquisition efforts.
Core Business Services also demonstrated steady growth, rising 3% year-over-year, supported by strong demand in Digital Operations and technology services.

View recap

GDI Integrated Facility Services Inc.

GDI.TO Q3 2025

Reported: 2025-11-07

GDI Integrated Facility Services reported Q3 2025 revenue of $615 million, reflecting a 4% year-over-year decline, while adjusted EBITDA remained stable at $38 million. The company anticipates stabilization and recovery in its business services segments in 2026.

Key takeaways

Revenue decline mainly attributed to a 4% organic decrease alongside earlier business disposals.
Technical Services demonstrated resilience with a record adjusted EBITDA of $19 million, despite economic uncertainties.
Business Services USA faced a significant 12% organic decline, primarily due to the loss of a major client and a shift away from low-margin accounts.
GDI successfully reduced long-term debt by $26 million, enhancing its capacity for future growth through mergers and acquisitions.
Management expects organic growth to stabilize in the first half of 2026, even amidst challenging market conditions.

View recap

Grupo Financiero Banorte, S.A.B. de C.V.

GFNORTEO.MX Q3 2025

Reported: 2025-11-07

Grupo Financiero Banorte reported strong third-quarter results despite a sequential net income decrease of 11%, influenced by extraordinary items. The core business showcases impressive resilience and growth across multiple segments, supported by effective margin management and capital optimization.

Key takeaways

Integrated margin expansion reflects cost of fund optimization and stronger consumer demand.
Net income experienced an 11% decline sequentially but remains 1% higher on an accumulated basis for the year.
ROE for the first nine months was solid at 22.3%, aligning with annual guidance.
The insurance business grew 20% year-to-date, significantly driven by increased billing and lending activity.
Loan portfolio, excluding government loans, expanded 10% year-over-year, primarily fueled by consumer lending growth.

View recap

Global Net Lease, Inc.

GNL Q3 2025

Reported: 2025-11-07

Global Net Lease (GNL) reported a robust performance in Q3 2025, achieving significant milestones in portfolio optimization, debt reduction, and operational stability, highlighted by an investment-grade credit rating from Fitch.

Key takeaways

Successfully executed a $1.8 billion sale of a multi-tenant retail portfolio, driving approximately $2 billion in net debt reduction since Q3 2024.
Enhanced financial flexibility through a refinancing of the revolving credit facility, resulting in a 35 basis point reduction in interest rate spread and extending debt maturity to 2030.
Share repurchase program completed with 12.1 million shares bought back at a weighted average price of $7.59, offering an AFFO yield of approximately 12%.
Portfolio remains strong with 97% occupancy across over 850 properties, predominantly occupied by investment-grade tenants (60%).
Continued strong leasing activity with renewal spreads averaging 26% above prior rents, underscoring the resilience of GNL's tenant base.

View recap

Genworth Financial, Inc.

GNW Q3 2025

Reported: 2025-11-07

Genworth Financial reported solid Q3 2025 results with net income of $116 million, bolstered by strong performance from its mortgage insurance subsidiary, Enact, which contributed significantly to earnings and capital returns.

Key takeaways

Adjusted operating income was $17 million, or $0.04 per share, reflecting resilience amidst market conditions.
Enact's strong cash flows led to $110 million in capital returns this quarter, totaling $1.2 billion since its IPO.
Genworth's long-term care (LTC) initiatives saw $44 million in gross incremental premium approvals with a significant average increase of 63%.
The CareScout network expanded to over 700 providers, achieving over 2,500 matches for LTC policyholders year-to-date, exceeding initial goals.
Strategic acquisition of Seniorly enhances CareScout's offerings, positioning Genworth for increased market share among aging consumers seeking care solutions.

View recap

Gold Resource Corporation

GORO Q3 2025

Reported: 2025-11-07

Gold Resource Corporation demonstrated signs of operational turnaround in Q3 2025, achieving significant production improvements and a solid cash position amid challenging market conditions.

Key takeaways

Strong cash position of over $9 million, bolstered by successful capital raising and disciplined cash management.
Commencement of production from the new high-grade Three Sisters area, validating prior expectations and enhancing profitability through improved mining methods.
Mining gross profit achieved during the quarter marks a key milestone on the path back to profitability despite cash costs remaining above long-term targets.
Record high precious metal prices have positively influenced cash flows, particularly through increased silver content in mined materials.
Steps taken to enhance workplace safety following multiple lost time injury incidents, including hiring an external consultant for a comprehensive safety assessment.

View recap

GeoPark Limited

GPRK Q3 2025

Reported: 2025-11-07

GeoPark Limited delivered strong third-quarter results, marked by increased production and a notable shift towards growth in Argentina following the acquisition of two new operational blocks in Vaca Muerta.

Key takeaways

Average consolidated production rose to 28,136 boe/d, exceeding 2025 guidance and a 3% increase quarter-over-quarter.
Adjusted EBITDA reached USD 71.4 million with a 57% margin; net income of USD 15.9 million showed significant recovery from prior losses.
The company plans to maintain a revised dividend program totaling approximately USD 6 million over the next four quarters while focusing on growth investments.
GeoPark successfully repurchased USD 108 million of its 2030 notes, realizing annual cash savings of USD 9.5 million and enhancing its capital structure.
The Board rejected an unsolicited nonbinding proposal from Parex, citing undervaluation and a commitment to maximizing shareholder value through strategic growth initiatives.

View recap

Grifols, S.A.

GRF.MC Q3 2025

Reported: 2025-11-07

Grifols delivered solid third-quarter performance with 7.7% revenue growth year-over-year, reflecting strong demand and effective cost management while facing external pressures.

Key takeaways

Year-to-date revenue reached EUR 5.5 billion, with a 10.5% increase on a like-for-like basis at constant currency.
Adjusted EBITDA for the third quarter was EUR 482 million, contributing to a total of EUR 1,358 million year-to-date, up 11.2% year-over-year.
Free cash flow improved significantly to EUR 188 million, marking a EUR 257 million increase versus the previous year.
Leverage ratio improved nearly 1x year-over-year to 4.2x, reflecting the company’s commitment to deleveraging.
Grifols remains on track to launch its fibrinogen therapy in Europe by late 2025 and is advancing strong clinical pipelines despite regulatory complexities.

View recap

Knight Therapeutics Inc.

GUD.TO Q3 2025

Reported: 2025-11-07

Knight Therapeutics reported its strongest financial results to date for Q3 2025, achieving record revenues of $122.6 million, driven by significant growth from its oncology portfolio and strategic acquisitions.

Key takeaways

Adjusted revenue rose 34% year-over-year, with a notable contribution of $25 million from the Paladin and Sumitomo portfolios.
Adjusted EBITDA reached $49 million for the first nine months of 2025, demonstrating robust operational efficiency.
Successful launches of three new products in key markets, including JORNAY PM in Canada and MINJUVI in Argentina, bolstered the revenue stream.
Despite setbacks with TAVALISSE and Qelbree regulatory submissions, the company remains committed to addressing regulatory requirements.
Knight initiated a Normal Course Issuer Bid (NCIB) to repurchase up to 3 million shares, enhancing shareholder value.

View recap

Hyatt Hotels Corporation

H Q3 2025

Reported: 2025-11-07

Hyatt reported a modest 0.3% RevPAR growth for Q3 2025, driven by robust performance in luxury brands and leisure transient segments despite challenges from holiday shifts and tough year-over-year comparisons.

Key takeaways

System-wide RevPAR grew 0.3%, with luxury brands achieving 6% growth in leisure transient segments.
The company completed a sale of a Playa hotel for $22 million and remains on track to close transactions for 14 hotels by year-end.
Net rooms growth reached over 12%, supported by significant new openings including Hyatt Regency Times Square and Park Hyatt Kuala Lumpur.
Strong development pipeline of approximately 141,000 rooms, driven predominantly by upper mid-scale brand entries in untapped markets.
World of Hyatt loyalty program membership surged 20% year-over-year to over 61 million, highlighting the brand's growing appeal.

View recap

Harvard Bioscience, Inc.

HBIO Q3 2025

Reported: 2025-11-07

Harvard Bioscience achieved strong operational advancements in Q3 2025, reporting revenues of $20.6 million and improved margins, while demonstrating robust customer engagement and a growing backlog ahead of the fourth quarter.

Key takeaways

Revenue of $20.6 million met guidance expectations, rebounding from a historically soft period.
Gross margin expanded to 58.4%, reflecting improved operational efficiency and a favorable product mix.
Customer order growth marked a year-over-year increase for the first time in over a year, driven by heightened demand and a growing product backlog.
Successful launch of the Incub8 Multiwell System bolstered market presence and initial customer feedback has been positive.
Strategic advances in capital structure highlight ongoing debt refinancing efforts, set for completion in Q4 2025.

View recap

Henkel AG & Co. KGaA

HEN3.DE Q3 2025

Reported: 2025-11-07

Henkel delivered strong organic sales growth in Q3 2025, driven by robust performance across both business units, with particularly notable gains in North America and enhanced momentum in Adhesive Technologies.

Key takeaways

Both business units achieved positive organic sales growth, highlighting effective strategies and operational resilience.
The company remains on track with its share buyback program, executing approximately EUR 700 million by the end of October.
Adhesive Technologies is well-positioned to benefit from megatrends in sustainability and AI, with significant growth anticipated in Electronics Solutions through 2030.

View recap

Heritage Insurance Holdings, Inc.

HRTG Q3 2025

Reported: 2025-11-07

Heritage Insurance Holdings reported a robust third quarter, achieving a net income of $50.4 million, reflecting strong operational execution and strategic focus on rate adequacy and underwriting discipline.

Key takeaways

Net income surged by 120% year-over-year, with in-force premiums reaching a record $1.44 billion.
New business premium increased 166% year-over-year, indicating a rebound in growth after recent strategic adjustments.
Policy count reduction moderated significantly, marking the smallest decline since strategic initiatives were implemented in mid-2021.
Strong agency relationships and data-driven underwriting are expected to support future growth and enhance shareholder value.
Positive trends in reinsurance pricing and industry litigation environment bode well for the company’s financial outlook in 2026.

View recap

International Consolidated Airlines Group, S.A.

IAG.MC Q3 2025

Reported: 2025-11-07

International Airlines Group (IAG) reported a solid Q3 2025, with a 2% increase in passenger revenue and strong operational margins at 22%, driven by robust travel demand and effective cost management.

Key takeaways

Operating profit up EUR 40 million YoY, aided by solid performances from Iberia and Aer Lingus.
Margins across all airlines exceeded 20%, with Iberia achieving a 23.7% margin.
Non-fuel costs improved quarter-on-quarter, despite growing employee pay commitments; IAG remains focused on maintaining competitive cost controls.
Plans to return excess cash to shareholders are underway, signaling confidence in ongoing value creation and balance sheet strength.
Anticipating stable demand in the long-haul market; Q4 revenue outlook remains positive despite currency headwinds.

View recap

iA Financial Corporation Inc.

IAG.TO Q3 2025

Reported: 2025-11-07

iA Financial Group reported strong Q3 2025 results with core EPS rising 18% year-over-year to $3.47, driven by robust sales and the successful acquisition of RF Capital Group.

Key takeaways

Core ROE reached 17.2%, surpassing the 2027 target of 17%.
Total premiums and deposits grew by 6% year-over-year, with assets under management up 15%.
The acquisition of RF Capital is expected to strategically enhance iA's market position despite a pro forma solvency ratio adjustment to 135%.
Individual insurance sales remained robust with net premiums increasing by 11%, and Dealer Services sales grew by 9%.
U.S. individual insurance sales saw a significant 15% rise, outperforming Canadian sales for the quarter.

View recap

International Consolidated Airlines Group, S.A.

ICAGY Q3 2025

Reported: 2025-11-07

International Airlines Group (IAG) reported a solid third quarter in 2025, with stable passenger revenues and high operating margins, maintaining strong demand for travel while managing costs effectively.

Key takeaways

Operating margin reached 22% for the quarter, with all airlines reporting margins over 20%.
Revenue increased by EUR 177 million (2% year-on-year), driven primarily by robust travel demand.
Iberia led operating profit growth, up EUR 56 million to EUR 510 million, with a margin of 23.7%.
Nonfuel costs improved, partially offsetting higher operational expenses due to pay deals and new aircraft.
The outlook for Q4 remains positive, although projected currency headwinds may impact revenue performance.

View recap

Intact Financial Corporation

IFC.TO Q3 2025

Reported: 2025-11-07

Intact Financial Corporation delivered strong Q3 2025 results, achieving a net operating income per share of $4.46, driven by robust underwriting performance and market share gains across all business lines.

Key takeaways

Top line growth of 6% complemented by a sub-90 combined ratio indicates solid margin management and operational efficiency.
The operating return on equity increased by 4 points to 20%, showcasing improved profitability across all regions.
Continued strong performance in Personal Lines and a 3% premium growth in Commercial Lines highlight successful growth initiatives, despite challenging market conditions in certain segments.
Strategic investments in AI are delivering over $150 million in annual recurring benefits, enhancing pricing and underwriting capabilities.
Plans for further market penetration in the UK and U.S. position the company well for sustained growth moving forward.

View recap

International Seaways, Inc.

INSW Q3 2025

Reported: 2025-11-07

International Seaways reported a strong Q3 2025 with net income of $71 million, driven by effective fleet management and a commitment to returning capital to shareholders.

Key takeaways

Adjusted net income stood at $57 million ($1.15 per diluted share) with adjusted EBITDA of $108 million.
The company announced a combined dividend of $0.86 per share, marking its fifth consecutive quarter with a payout ratio exceeding 75%.
Two new LR1 vessels were delivered during the quarter, financed through an $82 million facility, contributing to fleet modernization.
The sale of five older vessels generated $67 million, with plans to sell three more in Q4 for an additional $37 million.
Robust liquidity position with total liquidity of $985 million and a low net loan-to-value ratio of 13%.

View recap

Inuvo, Inc.

INUV Q3 2025

Reported: 2025-11-07

Inuvo, Inc. reported Q3 2025 revenues of $22.6 million, remaining flat year-over-year, but showcased strong year-to-date growth of 25% as the company adapts its strategy to meet client compliance needs.

Key takeaways

Q3 revenues were impacted by a strategic reduction in advertising spend in response to new client requirements; however, October saw a rebound in revenue.
The firm secured key client contracts anticipated to drive 65% growth from top clients by the end of 2025.
Inuvo expects a significant financial benefit from a settled class action lawsuit, with payouts anticipated in Q1 2026.
The appointment of COO Rob Buchner enhances business development efforts, particularly in pursuing high-value enterprise contracts.
Overall, Inuvo remains optimistic about meeting its revenue goals for 2025, with a focus on scalable growth initiatives going forward.

View recap

Jazz Pharmaceuticals plc

JAZZ Q3 2025

Reported: 2025-11-07

Jazz Pharmaceuticals achieved record revenues of over $1.1 billion in Q3 2025, fueled by strong sales across its product portfolio and two significant FDA approvals, paving the way for continued growth and strategic advancements.

Key takeaways

Secured FDA approvals for Modeyso and Zepzelca, expanding treatment options for severe conditions.
Strong commercial performance driven by Xywav's 11% year-over-year growth, contributing $431 million in net sales.
Narrowed 2025 revenue guidance to $4.175 billion - $4.275 billion, reflecting confidence in future performance.
Completed settlements in Xyrem antitrust litigation, allowing focus on strategic execution and shareholder value.
Strengthened the pipeline with the Saniona licensing agreement for a promising epilepsy candidate, SAN2355.

View recap

Janus International Group, Inc.

JBI Q3 2025

Reported: 2025-11-07

Janus International Group reported third-quarter 2025 revenue of $219.3 million, reflecting a 4.7% year-over-year decline, though adjusted EBITDA rose 1.2% to $43.6 million, highlighting resilience amid challenging market conditions.

Key takeaways

Self-storage revenue increased by 3.7%, supported by strong international growth despite North American softening.
Commercial and Other segment revenues decreased 20.1%, largely due to TMC project timing and LTL trucking industry weakness.
Adoption of Noke Smart Entry system grows significantly, with 439,000 units installed, up 35.9% year-over-year.
Continued investment in product innovation, including the launch of a new metal decking line and enhancements to the Noke platform.
Share repurchase program persists, with focus on M&A opportunities to leverage robust cash flow generation.

View recap

Joby Aviation Inc. Common Stock

JOBY Q3 2025

Reported: 2025-11-07

Joby Aviation achieved a pivotal milestone in its certification journey by commencing power-on testing for its first aircraft intended for Type Inspection Authorization (TIA), showing strong operational performance amid increasing production capacity.

Key takeaways

Initiated power-on testing for TIA, representing a critical step in the FAA certification process.
Demonstrated operational capabilities with multiple successful flights, including a notable mission during the California International Air Show.
Engaged in the eIPP program discussions, positioning the company to leverage early demand for eVTOL operations ahead of full certification.
Expanded production significantly, producing 15x more FAA-conforming parts in 2025 compared to all of 2024, including new propeller blade manufacturing in Ohio.
Ongoing job creation in the manufacturing sector, with over 100 new roles added in Q3.

View recap

Kennedy-Wilson Holdings, Inc.

KW Q3 2025

Reported: 2025-11-07

Kennedy-Wilson reported strong Q3 2025 results with significant growth in adjusted EBITDA and a successful expansion of its investment management platform, highlighted by a notable increase in assets under management.

Key takeaways

Adjusted EBITDA rose to $125 million, nearly doubling from $66 million in Q3 2024; year-to-date adjusted EBITDA increased 6% to $371 million.
Assets under management reached $31 billion, an 11% year-over-year increase, while fee-bearing capital grew by 10% to $9.7 billion.
The company deployed approximately $900 million in Q3, contributing to a total of $3.5 billion year-to-date, with a focus on rental housing investments.
Kennedy-Wilson achieved $470 million in cash from asset sales year-to-date, surpassing its target of $400 million for the year.
A pending acquisition of Toll Brothers Apartment Living is set to significantly enhance its investment management platform, adding $5 billion in assets and scaling total AUM to approximately $36 billion.

View recap

Lamar Advertising Company (REIT)

LAMR Q3 2025

Reported: 2025-11-07

Lamar delivered resilient Q3 2025 results with a 2.9% year-over-year revenue growth, driven by strength in national/programmatic advertising and digital billboards, despite ongoing macroeconomic challenges.

Key takeaways

Acquisition-adjusted operating expenses rose 3.7%, primarily due to severance costs and technology implementation, but remained within revised guidance.
Adjusted EBITDA increased 3.5% year-over-year to $280.8 million, maintaining a strong adjusted EBITDA margin of 48%.
Successful capital transactions included raising $1.1 billion, enhancing the company’s already strong balance sheet and liquidity position.
Digital billboard revenue grew by 5%, representing 31% of total billboard billing, as Lamar continues to enhance its digital offerings.
Encouraging conversations with customers about 2026 indicate potential for strong growth, despite Q4 2025 likely facing challenges from political advertising.

View recap

Gladstone Land Corporation

LAND Q3 2025

Reported: 2025-11-07

Gladstone Land Corporation demonstrated prudent asset management in Q3, achieving a significant property sale and adjusting lease structures to optimize revenue amid challenging market conditions.

Key takeaways

Completed the sale of two farms in Florida for $21.5 million, generating a $6 million gain and a 36% premium over the original purchase price.
Adjusted the lease structures on six permanent crop properties to lower tenant costs and share in revenue growth, indicating flexible asset management.
Anticipates approximately $17 million in fourth-quarter revenue from recent harvests of almonds, pistachios, and grapes, signaling strong production levels.
Executed two lease renewals post-quarter, projecting a 7% increase in annual NOI.
Evaluating additional farm sales and lease transitions to enhance cash flow strategies and mitigate risks associated with high interest rates.

View recap

Lantheus Holdings, Inc.

LNTH Q3 2025

Reported: 2025-11-07

Lantheus reported a solid third quarter in 2025, showcasing resilience in its core PSMA PET franchise despite a slight dip in sales, alongside strategic leadership transitions and preparations for the upcoming F-18 PET formulation launch.

Key takeaways

Q3 sales for PYLARIFY reached $240.6 million, reflecting a year-over-year decrease of 7%, but U.S. volumes showed a positive 3.3% increase.
The company announced a leadership transition with Mary Anne Heino stepping in as interim CEO post Brian Markison's retirement, ensuring continuity in strategic execution.
Lantheus is preparing for the expected launch of the new F-18 PSMA PET formulation in 2026, which aims to enhance production efficiency and patient access.
DEFINITY maintained a strong performance with over 6% year-over-year growth, underscoring its market leadership in ultrasound-enhancing agents.
The neurology franchise, especially Neuraceq, is positioned for growth driven by increasing demand in the Alzheimer's disease imaging market.

View recap

Grand Canyon Education, Inc.

LOPE Q3 2025

Reported: 2025-11-07

Grand Canyon Education delivered robust growth in the third quarter of 2025, characterized by a 9.6% increase in online enrollment and a strong performance in hybrid programs, despite slight declines in traditional campus enrollment.

Key takeaways

Online campus new starts rose mid-single digits, totaling 9.6% enrollment growth, aligning with long-term strategic objectives.
Hybrid campus enrollments surged 17.4% year-over-year, driven by the introduction of affordable online prerequisite courses.
Traditional ground campus enrollment remained flat due to prior year challenges, but early indicators for fall 2026 suggest positive recruitment momentum.
Strategic partnerships with over 5,500 employers continue to support curriculum relevance and retention, enhancing GCU’s competitive position.
Strong demand for healthcare programs, particularly in nursing, positions GCU well amidst rising interest among younger students.

View recap

Legrand SA

LR.PA Q3 2025

Reported: 2025-11-07

Legrand achieved robust growth in sales with a 14.5% increase year-to-date, supported by strong performance in data centers and strategic acquisitions, while maintaining solid profitability margins.

Key takeaways

Sales increased 14.5% excluding FX, with organic growth of 8.2%, primarily driven by a 30% rise in data center revenues.
Adjusted operating margin improved to 20.7%, up 20 bps year-on-year, reflecting robust operational execution and adaptation to market conditions.
Announced seven acquisitions to enhance presence in energy and digital sectors, with a total annualized sales contribution of approximately EUR 500 million.
Free cash flow increased by 16.3% to EUR 871 million, indicating strong cash generation capabilities.
Full-year guidance reaffirms growth targets of 10% to 12% and operating margin of 20.5% to 21%, aligning with previous forecasts.

View recap

Lyft, Inc.

LYFT Q3 2025

Reported: 2025-11-07

Lyft posted a record third quarter with significant growth in active riders, gross bookings, and adjusted EBITDA, alongside its first-ever $1 billion free cash flow generation.

Key takeaways

Active riders grew 18% year-over-year, achieving an all-time high, with gross bookings up 16%.
Adjusted EBITDA increased by 29%, reflecting strong operational efficiency and profit potential.
Strategic partnership with United Airlines now live, enhancing customer incentives and expanding growth avenues.
Anticipated continued growth momentum in Q4, with rides projected to increase mid- to high teens and gross bookings up 17% to 20%.
Ongoing advancements in autonomous vehicle partnerships and underpenetrated market opportunities expected to drive performance into 2026.

View recap

MetLife, Inc.

MET Q3 2025

Reported: 2025-11-07

MetLife delivered strong third-quarter results, with adjusted earnings rising 22% year-over-year to $1.6 billion, driven by robust investment margins and operational efficiencies.

Key takeaways

Adjusted earnings reached $1.6 billion or $2.34 per share, exceeding expectations with strong contributions from variable investment income and volume growth.
Group Benefits segment reported a 6% increase in adjusted earnings, supported by improved disability and dental profitability.
Adjusted earnings from Asia surged 36%, bolstered by a 34% rise in sales, particularly strong in Japan.
MetLife's new Accelerator platform in Latin America has secured over 20 partners, generating $340 million in annualized premiums since launch.
Adjusted return on equity reached 16.7%, aligning with the company's targets and showcasing the effectiveness of the New Frontier strategy.

View recap

Mistras Group, Inc.

MG Q3 2025

Reported: 2025-11-07

MISTRAS Group reported robust Q3 2025 results, achieving a 7% year-over-year revenue growth driven by strong performance across all major end markets, with record adjusted EBITDA highlighting improved operating leverage.

Key takeaways

Consolidated revenue reached $85.4 million, with net income of $13.1 million and earnings per diluted share of $0.41.
Gross profit increased by 19% year-over-year, resulting in a gross margin expansion of 300 basis points to 29.8%.
Notable growth in the energy sector at 8.1%, particularly from power generation services, boosted by demand for renewable offerings.
Strategic initiatives included enhancing offerings and diversifying client bases, exemplified by new projects with Batchelor & Kimball and Bechtel.
Record quarterly adjusted EBITDA stood at $30.2 million, reflecting a 29.6% increase from the prior year, underscoring improved operational efficiencies.

View recap

Melco Resorts & Entertainment Limited

MLCO Q3 2025

Reported: 2025-11-07

Melco Resorts & Entertainment reported strong Q3 2025 performance with group-wide adjusted property EBITDA rising 18% year-over-year to approximately $380 million, driven by robust recovery in Macau and significant growth in the Philippines and Cyprus.

Key takeaways

Macau property EBITDA increased by 21% year-over-year, achieving record mass table GGR in October.
Strong momentum in the Philippines with 45% quarter-over-quarter EBITDA growth; Cyprus property EBITDA rose 53% year-over-year.
Liquidity remains strong at $2.6 billion, with a cash balance increase of $360 million, facilitating ongoing debt repayments.
Introduction of new premium offerings, including the Signature Clubhouse at City of Dreams, enhancing customer engagement.
Continued operational discipline maintained with steady OpEx at approximately $3 million per day.

View recap

Miller Industries, Inc.

MLR Q3 2025

Reported: 2025-11-07

Miller Industries reported a challenging third quarter in 2025 with a significant drop in net sales, primarily due to decreased chassis shipments, yet implemented strategic measures to enhance operational efficiency and cash flow.

Key takeaways

Net sales fell 43.1% year-over-year to $178.7 million, driven by reduced chassis shipments.
Gross profit margin improved to 14.2%, aided by a favorable product mix.
Cash balance increased by $6.6 million sequentially to $38.4 million, reflecting effective cash management and inventory adjustments.
Debt reduced by $10 million to $45 million during the quarter, with a further reduction to $35 million post-Q3.
Strategic production adjustments aimed at normalizing inventory levels are anticipated to position the company favorably for recovery in 2026.

View recap

Maravai LifeSciences Holdings, Inc.

MRVI Q3 2025

Reported: 2025-11-07

Maravai LifeSciences reported Q3 2025 total revenues of $41.6 million, marked by a 7% growth in Biologic Safety Testing, but a significant 53% decline in Nucleic Acid Products year-over-year. Cost restructuring efforts are on track, aiming for positive adjusted EBITDA by 2026.

Key takeaways

Biologic Safety Testing revenue reached $16.3 million, benefiting from strong demand in core markets, particularly in the Americas and Europe.
Nucleic Acid Products saw a 53% revenue decline, largely due to COVID-related order timing, though growth is anticipated in Q4.
Management expects an annualized expense reduction exceeding $50 million and projects over $7 million in sequential adjusted EBITDA improvement in Q4.
New product innovations like ModTail technology and IVT kits are gaining traction and could significantly enhance revenue streams moving forward.
Cygnus remains a leader in the Biologic Safety Testing space, maintaining 100% market coverage in CAR-T and gene therapy products.

View recap

Marex Group plc Ordinary Shares

MRX Q3 2025

Reported: 2025-11-07

Marex achieved robust Q3 2025 results with a 25% year-on-year increase in adjusted profit before tax to $101 million, driven by strong performance in its Clearing and Prime Services segments despite challenging market conditions.

Key takeaways

Adjusted profit before tax for the first nine months of 2025 reached $303 million, up 26% year-on-year.
Q3 revenues increased 24% to $485 million, enhancing margins to 20.9%.
The Clearing segment saw a 4% quarter-over-quarter increase in average client balances, bolstered by strong client onboarding.
Prime Services generated $171 million in revenue in the first nine months after acquisition, now representing nearly 25% of total profits.
The company is pursuing M&A opportunities to further diversify and enhance growth, including the recent acquisition of Winterflood.

View recap

National Australia Bank Limited

NAB.AX Q4 2025

Reported: 2025-11-07

National Australia Bank (NAB) reported stable cash earnings for FY2025, supported by a 5.8% growth in business lending and a positive revenue trajectory despite higher impairment charges.

Key takeaways

Cash earnings were stable year-over-year, with a total dividend of $1.70 for FY2025, maintaining a payout ratio of 73.3%.
Revenue increased by 2.9%, driven by strong volume growth and improved market conditions in business credit.
NAB's common equity Tier 1 capital ratio stood at 11.7%, comfortably meeting targets while maintaining robust provisioning levels.
The bank's strategic focus on customer advocacy is yielding tangible improvements, with 12 out of 20 priority areas showing enhanced outcomes.
NAB's position as the top business lender in Australia highlights its effective balance sheet management and market growth strategies.

View recap

Nature's Sunshine Products, Inc.

NATR Q3 2025

Reported: 2025-11-07

Nature's Sunshine achieved record third-quarter net sales of $128.3 million, reflecting a robust 12% year-over-year growth driven by strategic investments and strong execution across key markets.

Key takeaways

Record net sales in Q3 2025 reached $128.3 million, up from $114.6 million in the same period last year.
Significant digital sales growth of 52% year-over-year, with new digital customer purchases more than doubling.
Over half of direct-to-consumer orders now come from subscription auto ship programs, enhancing customer retention and revenue predictability.
Strong performance across regions, particularly in North America and Asia Pacific, indicating effective transformation initiatives.
Continued focus on digital capabilities, cost management, and field engagement sets the stage for sustained profitable expansion.

View recap

Novo Nordisk A/S

NOVO-B.CO Q3 2025

Reported: 2025-11-07

Novo Nordisk reported robust Q3 2025 results, achieving 15% sales growth and 10% operating profit growth, while narrowing guidance due to anticipated lower growth in GLP-1 diabetes and obesity treatments.

Key takeaways

Approved Rybelsus with cardiovascular indications in the U.S. and EU, enhancing portfolio in diabetes care.
Obesity care sales surged 41%, significantly boosted by a 168% increase in Wegovy, underscoring strong demand.
Initiated a company-wide transformation expected to lead to DKK 8 billion in annual savings by 2026, focusing resources on diabetes and obesity.
Operational efficiency improvements are anticipated from the reduction of approximately 9,000 global positions, aiming to enhance shareholder returns.

View recap

Nerdy Inc. Class A Common Stock

NRDY Q3 2025

Reported: 2025-11-07

Nerdy, Inc. faced challenges in Q3 2025 due to delays in product launches and technical debt impacting growth, but made significant strides in replatforming its core systems leveraging AI, positioning the company for improved performance moving forward.

Key takeaways

Product launch delays during the back-to-school season hindered expected growth and profitability.
Significant progress in transitioning to AI-assisted software development, aiming for nearly 100% new code base by November.
New features, including a unified student-tutor interface and the AI Practice Hub, are driving improved user engagement and retention.
Early indications show a 50% increase in consumption of self-study tools and positive trends in tutor quality through enhanced vetting processes.
Focus for Q4 includes enhancing customer discovery and onboarding with gamification and other innovative features.

View recap

NRG Energy, Inc.

NRG Q3 2025

Reported: 2025-11-07

NRG Energy reported a robust third quarter with adjusted EPS rising 32% year-over-year and confirmed a $100 million increase in 2025 financial guidance, driven by strong performance across Energy and Smart Home segments.

Key takeaways

Adjusted EBITDA reached a record high, reflecting successful margin improvements and operational efficiencies.
Expanded data center power agreements to a total of 445 megawatts, with new pricing targets raised above $80 per megawatt hour.
LS Power acquisition is on track for a first quarter 2026 close, enhancing NRG's competitive positioning and projected 14% EPS CAGR through 2029.
Year-to-date adjusted EPS is up 36%, supporting the company's long-term growth targets.

View recap

Intellia Therapeutics, Inc.

NTLA Q3 2025

Reported: 2025-11-07

Intellia Therapeutics faced significant challenges in Q3 2025, including a clinical hold on its nex-z program following serious safety concerns, while making substantial progress in its lonvo-z development for hereditary angioedema.

Key takeaways

The FDA imposed a clinical hold on both the MAGNITUDE and MAGNITUDE-2 trials of nex-z due to safety issues, including increased liver enzyme levels in a patient who later passed away.
Enrollment for the Phase III trial of lonvo-z was completed ahead of schedule, with top-line data expected by mid-2026 and a potential U.S. launch in early 2027.
Intellia's cash position remains strong at $669.9 million, bolstered by a $115 million capital raise, extending its cash runway into mid-2027.
Collaboration revenue climbed to $13.8 million, primarily due to cost reimbursements from Regeneron Pharmaceuticals, reflecting active partnerships.
R&D expenses decreased to $94.7 million, driven by cost-cutting measures, highlighting the company's focus on managing operational expenditures amidst program uncertainties.

View recap

Natera, Inc.

NTRA Q3 2025

Reported: 2025-11-07

Natera reported robust Q3 2025 results, with revenue growth of 35% year-over-year driven by strong demand for its clinical products, particularly Signatera, alongside a notable improvement in gross margins.

Key takeaways

Revenue for the quarter reached $592 million, significantly exceeding last year’s performance.
Clinical MRD tests exceeded 202,000, marking record growth with 21,500 additional units.
Gross margins surged to 64.9%, reflecting efficiency gains and cost management.
The company raised its 2025 revenue guidance by $160 million, now forecasting $2.18–$2.26 billion.
Expanding the product offering with the new Fetal Focus test, targeting over 20 genes with positive initial feedback.

View recap

Nova Measuring Instruments Ltd.

NVMI Q3 2025

Reported: 2025-11-07

Nova reported record quarterly revenue of $224.6 million in Q3 2025, achieving 25% year-over-year growth driven by strong demand across advanced nodes and packaging solutions.

Key takeaways

Record sales in memory driven by strong demand for advanced DRAM and high-bandwidth memory solutions.
Advanced logic revenue surged with major orders for the ELIPSON materials metrology platform validated for high-volume production.
Significant expansion in advanced packaging solutions, highlighted by the successful launch and adoption of the Nova WMC platform.
New production facility in Mannheim, Germany, opened to triple capacity for advanced packaging optical metrology solutions.
2025 guidance indicates continued growth trajectory, expected to reach approximately 30% year-over-year at the midpoint.

View recap

Novo Nordisk A/S

NVO Q3 2025

Reported: 2025-11-07

Novo Nordisk reported strong Q3 2025 results with a 15% increase in sales and 10% rise in operating profit, while narrowing its sales and operating profit guidance due to projected slower growth in its GLP-1 treatments.

Key takeaways

Sales growth was driven by both U.S. (15%) and international operations (16%), bolstered by one-off adjustments in the U.S. of DKK 6 billion.
Obesity care surged 41%, led by a 24% growth in U.S. sales and an impressive 83% growth internationally.
The company is executing a strategic transformation involving a reduction of approximately 9,000 global positions, expected to yield annual savings of DKK 8 billion by 2026.
Rybelsus received regulatory approval in the U.S. and EU, enhancing Novo's offerings in diabetes care.
Ongoing focus on diabetes and obesity, coupled with portfolio refinement, reaffirms Novo Nordisk's commitment to addressing major unmet medical needs.

View recap

Universal Display Corporation

OLED Q3 2025

Reported: 2025-11-07

Universal Display Corporation reported Q3 2025 revenues of $140 million, reflecting a year-over-year decline, primarily due to timing dynamics in customer orders, while investments in R&D and strategic acquisitions signal a commitment to future growth.

Key takeaways

Revenue declined to $140 million compared to $162 million in Q3 2024 and $478 million year-to-date, with a full-year estimate expected at the lower end of $650 million to $700 million.
The company announced plans to acquire OLED patent assets from Merck KGaA for $50 million, enhancing its R&D capabilities for next-generation OLED technologies.
Royalty and licensing revenue fell to $53 million, adversely impacted by a one-time adjustment of $9.5 million.
Green emitter sales showed growth at $65 million while red emitter sales decreased to $17 million.
Future growth anticipated as rising OLED adoption drives expansion, with significant new manufacturing capacity expected to come online in 2026.

View recap

Olaplex Holdings Inc. Common Stock

OLPX Q3 2025

Reported: 2025-11-07

Olaplex Holdings reported third-quarter fiscal 2025 results that slightly exceeded expectations, demonstrating early signs of improvement in brand performance and effective execution of strategic initiatives.

Key takeaways

Net sales were $114.6 million, down 3.8% year-over-year, but better than anticipated due to early shipment timing.
Adjusted EBITDA reached $30.8 million with a margin of 26.9%, benefiting from robust sales flow-through.
Significant marketing investments are yielding positive brand perception shifts, enhancing emotional connection and consumer engagement.
A successful launch of two new hair masks marked the company's most integrated product introduction, featuring a comprehensive 360-degree marketing campaign.
Sales trends showed improvement in professional channels, signaling recovery and growth potential in previously reset markets.

View recap

Onity Group Inc.

ONIT Q3 2025

Reported: 2025-11-07

Onity Group reported robust third-quarter performance, bolstered by record origination volumes and strong servicing profitability, resulting in increased adjusted pretax income and return on equity.

Key takeaways

Adjusted pretax income reached $31 million with an annualized return on equity of 25%, exceeding guidance.
GAAP net income reported at $2.03 per share, inclusive of a $0.48 tax provision linked to strategic planning.
Year-over-year servicing portfolio growth of 6%, driven by $39 billion in servicing additions, outpacing planned transfers and sales.
Originations volume surged 39% compared to last year, marking the highest funded volume recorded with a market size considerably lower than the 2021 peak.
Continuous investment in technology and optimization strategies is enhancing customer experience and operational efficiency across channels.

View recap

OptimizeRx Corporation

OPRX Q3 2025

Reported: 2025-11-07

OptimizeRx reported a robust Q3 2025 with revenues of $26.1 million, reflecting a 22% year-over-year growth, and an adjusted EBITDA of $5.1 million, exceeding expectations.

Key takeaways

Revenue guidance for FY 2025 has been raised to $105-$109 million, with adjusted EBITDA now expected between $16-$19 million.
Average revenue from the top 5 customers has grown beyond $11 million, demonstrating strong client relationships and engagement.
The company continues to reduce its debt, paying down an additional $2 million, and does not anticipate needing to access equity capital markets in the near future.
Gross margin improved to 67.2%, driven by a favorable product and channel mix, alongside disciplined cost management efforts.
Initial guidance for FY 2026 indicates revenue of $118-$124 million and adjusted EBITDA of $19-$22 million, signaling confidence in future growth.

View recap

Oscar Health, Inc.

OSCR Q3 2025

Reported: 2025-11-07

Oscar Health reported a 23% year-over-year increase in revenue for Q3 2025, although losses widened due to higher market morbidity. The company remains optimistic about profitability improvements in 2026.

Key takeaways

Total revenue reached approximately $3 billion, with an adjusted EBITDA loss of $101 million.
Membership increased by 28% year-over-year, surpassing 2 million members.
The company implemented a disciplined pricing strategy for 2026, with a weighted average rate increase of about 28%.
New innovative products, including HelloMeno, are designed to capture additional market share and cater to women's health.
Oscar is integrating an AI health agent, Oswell, across its product offerings to enhance member engagement and support.

View recap

PDF Solutions, Inc.

PDFS Q3 2025

Reported: 2025-11-07

PDF Solutions, Inc. reported strong third-quarter performance, driven by robust bookings and strategic technology partnerships that bolster their position in AI-driven analytics within the semiconductor industry.

Key takeaways

Secured multiple 8-figure contracts, including agreements to expand AI analytics capabilities with a large IC manufacturer and a prominent equipment OEM.
Integrated Tiber AI Studio into Exensio, enhancing AI model management and deployment, addressing customers' needs for efficient scaling of AI applications.
Strong revenue contributions from Cimetrix connectivity software, marking the highest performance since its acquisition, positioning PDF as a leader in connectivity solutions.
Customer base has grown from 150 to over 370 since 2020, now encompassing major players in the equipment and cloud sectors.
Continued investments in product development and infrastructure are expected to enhance profitability and balance sheet strength by 2026.

View recap

Penumbra, Inc.

PEN Q3 2025

Reported: 2025-11-07

Penumbra reported strong third-quarter results for 2025, achieving $354.7 million in revenue driven by robust growth across its U.S. thrombectomy and embolization franchises, highlighting its competitive positioning and successful product innovation.

Key takeaways

Total revenue increased by 17.8% year-over-year, with U.S. revenue growing 21.5% to $275 million.
The VTE franchise achieved remarkable 34% year-over-year growth, affirming its market leadership.
Gross margin expanded to 67.8%, with operating income at $48.8 million (13.8% of revenue), and future margins are projected to exceed 70%.
FDA clearance for breakthrough products Lightning Bolt 16 and Lightning Flash 3.0 enhances Penumbra's advanced CAVT device portfolio.
The integration of a dedicated embolization sales team has resulted in a 21.2% sequential revenue increase in this segment.

View recap

Pharming Group N.V.

PHARM.AS Q3 2025

Reported: 2025-11-07

Pharming Group N.V. achieved robust growth in Q3 2025, with total revenues increasing by 30% year-over-year to $82 million, driven by strong performance in its commercial products RUCONEST and Joenja.

Key takeaways

Operating profit surged nearly fourfold to $15.8 million, with operating cash flow reaching $32 million.
RUCONEST revenue grew 29%, benefiting from increased prescriber adoption and new patient enrollments.
Joenja saw a 35% revenue increase, supported by a 25% rise in U.S. patients on therapy and an expanding patient funnel.
The company raised its full-year 2025 revenue guidance to a range of $360 million to $375 million, reflecting ongoing commercial momentum.
Planned reductions in G&A headcount will optimize capital for high-growth initiatives, enhancing Pharming's competitive positioning in the rare disease market.

View recap

Playtika Holding Corp.

PLTK Q3 2025

Reported: 2025-11-07

Playtika reported a strong Q3 2025, driven by record direct-to-consumer revenue and exceptional performance from Disney Solitaire, although it faced challenges from a declining Slotomania.

Key takeaways

Total revenue reached $674.6 million, marking an 8.7% year-over-year increase despite a 3.1% sequential decline.
Direct-to-consumer revenue surpassed $209 million, up 19% sequentially and contributing 31% of total revenue.
Disney Solitaire is on track for a $200 million annualized run rate, the fastest scaling title in Playtika's history.
Slotomania revenue dropped 20.8% sequentially and 46.7% year-over-year as the company rebalanced the game economy.
Adjusted EBITDA rose 30.2% sequentially to $217.5 million, reflecting improved operating margins and disciplined marketing expenditure.

View recap

Insulet Corporation

PODD Q3 2025

Reported: 2025-11-07

Insulet Corporation delivered a remarkable third quarter in 2025, achieving over $700 million in revenue, reflecting a 28% year-over-year growth, driven by strong customer retention and expansion in both Type 1 and Type 2 markets.

Key takeaways

Surpassed $700 million in quarterly revenue for the first time, demonstrating the strength of its recurring revenue model.
Operating margins increased by 90 basis points to 17.1%, reflecting efficient cost management alongside investments in innovation.
New customer starts in the U.S. Type 2 market more than doubled year-over-year, highlighting strong momentum and effective outreach strategies.
International revenue grew 40% year-over-year, driven by successful global launches, including Omnipod 5, and strong demand in established markets.
The expanded leadership team aims to further enhance Insulet's market position and customer experience across various segments.

View recap

Primo Brands Corporation

PRMB Q3 2025

Reported: 2025-11-07

Primo Brands Corporation reported a resilient Q3 2025 performance with net sales reaching $1.766 billion, reflecting a slight year-over-year decline but improved operational efficiency leading to significant adjusted EBITDA growth.

Key takeaways

Net sales declined 1.6% year-over-year, but improved from a 2.5% decline in Q2 2025, showcasing customer retention efforts.
Adjusted EBITDA rose 6.8% to $404.5 million, resulting in a margin increase to 22.9%.
Delivery service rates recovered to 95% as integration challenges were addressed, supporting future growth potential.
The company remains on track to achieve synergy targets of $200 million by the end of 2025 and $300 million by 2026.
Eric Foss has been appointed as Chairman and CEO, expected to drive brand growth and operational excellence moving forward.

View recap

Priority Technology Holdings, Inc.

PRTH Q3 2025

Reported: 2025-11-07

Priority Technology Holdings demonstrated solid growth in Q3 2025, with net revenue increasing by 6% and adjusted EPS rising 56% year-over-year.

Key takeaways

Revenue reached $241.4 million, driven by strong performance in Payables and Treasury Solutions, which saw 14% and 18% growth, respectively.
Adjusted gross profit margin improved to 39.2%, reflecting the ongoing success in high-margin segments despite moderated growth in Merchant Solutions.
The company revised its full-year revenue guidance to a range of $950 million to $965 million, anticipating growth of 8% to 10%, while raising adjusted gross profit guidance to $370 million at the low end.

View recap

Privia Health Group, Inc.

PRVA Q3 2025

Reported: 2025-11-07

Privia Health reported robust third-quarter results, marked by significant growth in practice collections and adjusted EBITDA, leading to an upward revision of its 2025 financial guidance.

Key takeaways

Implemented provider growth of 13.1% year-over-year, reaching 5,250, driving practice collections up 27.1% to $940.4 million.
Adjusted EBITDA surged 61.6%, expanding the EBITDA margin to 30.5%, a 720 basis point improvement from the prior year.
Increased total attributed lives by nearly 13% year-over-year, with plans to further expand through the acquisition of an ACO business from Evolent Health, enhancing market presence and value-based services.

View recap

PSQ Holdings, Inc.

PSQH Q3 2025

Reported: 2025-11-07

PublicSquare reported a strong performance in Q3 2025, exceeding revenue guidance by 10% with a notable year-over-year revenue growth of 37%, driven primarily by its expanding fintech division.

Key takeaways

Fintech revenue surged by 28% quarter-over-quarter, with payments revenue up 50%.
Operating expenses decreased by 13% year-over-year, leading to a 33% reduction in net loss compared to the same period in 2024.
General and administrative expenses saw a significant drop of 22.3%, reflecting continued expense discipline and optimization strategies.
Improvements in underwriting practices contributed to enhanced credit portfolio performance, with a 22% quarter-over-quarter revenue increase from the credit business.
The company reaffirmed its revenue guidance for Q4 2025 and full year 2026, indicating confidence in sustained fintech growth.

View recap

P10 Inc. Class A Common Stock

PX Q3 2025

Reported: 2025-11-07

P10 delivered strong third-quarter results, raising $915 million in gross fee-paying assets under management, driving total AUM to $29.1 billion, a year-over-year increase of 17%. The company exceeded its fundraising guidance for 2025, raising its target to nearly $5 billion.

Key takeaways

Third quarter marked the successful raise and deployment of $915 million in new fee-paying AUM, showcasing robust capital commitments.
Year-to-date fee-related revenue increased by 5%, excluding catch-up fees, reflecting ongoing demand for P10's investment strategies.
Launch of four new funds and strong performance of Secondary Fund V, closing at $1.26 billion, highlights continued growth in P10's commingled fund business.
The company is well-positioned to capture opportunities in the middle and lower-middle markets, driven by secular demand trends.
P10 announced a dual listing on NYSE Texas, enhancing its engagement with the investment community.

View recap

AVITA Medical, Inc.

RCEL Q3 2025

Reported: 2025-11-07

AVITA Medical reported Q3 2025 revenues of approximately $17 million, falling short of expectations due to ongoing reimbursement disruptions, but anticipates renewed demand and adoption for its RECELL product following resolution of payment clarity.

Key takeaways

Revenue guidance for the full year adjusted to $70 million to $74 million, down from $76 million to $81 million.
All seven regional Medicare Administrative Contractors have established reimbursement rates for RECELL, enhancing clinician confidence and adoption.
The company is refining its commercial strategies, focusing on approximately 200 key burn centers, representing a $1.3 billion opportunity within the broader $3.5 billion U.S. market.
Recent CE Mark approval for RECELL GO expands access to the technology in Europe, with the first patient treated in Germany.
Management's immediate priorities include revitalizing order momentum, driving consistent product utilization, and finalizing the transition of the commercial organization for improved performance.

View recap

Redwire Corporation Common Stock

RDW Q3 2025

Reported: 2025-11-07

Redwire Corporation reported impressive Q3 2025 results, with significant revenue growth and improved margins following its strategic acquisition of Edge Autonomy. However, potential delays in government contracts due to the ongoing U.S. government shutdown may impact short-term performance.

Key takeaways

Revenue surged 67.5% sequentially and 57% year-over-year, reaching $103.4 million.
Adjusted gross margin improved to 27.1%, with a $24.8 million increase in adjusted EBITDA.
Book-to-bill ratio of 1.25 resulted in a backlog of $355.6 million, driven by strong customer demand.
Near-term government contract delays are anticipated due to the ongoing shutdown, though long-term demand remains strong.
Redwire is positioned as a leader in next-gen space technologies, particularly in VLEO and GEO with key partnerships and contracts.

View recap

Remitly Global Inc. Common Stock

RELY Q3 2025

Reported: 2025-11-07

In Q3 2025, Remitly reported a robust 25% revenue growth alongside a 15% adjusted EBITDA margin, demonstrating strong operational execution and sustained investment in business expansion.

Key takeaways

Business segment growth accelerated with nearly 10,000 companies now using the platform, doubling send volume sequentially.
Reliability metrics improved significantly, achieving 99.99% uptime and facilitating rapid transaction completion—over 94% within an hour.
The expansion of send limits for U.S. customers to $100,000 has driven over 40% year-over-year volume growth among high-amount senders.
Continued strategic investments in customer-centric pricing and targeted marketing are enhancing Remitly's competitive positioning in the global payments market.

View recap

Sturm, Ruger & Company, Inc.

RGR Q3 2025

Reported: 2025-11-07

Sturm, Ruger & Company reported a modest year-over-year sales increase to $126.8 million for Q3 2025 amidst ongoing market challenges, while losses per share were significantly impacted by operational costs and strategic investments.

Key takeaways

Net sales increased by 3.7% year-over-year, but diluted earnings per share decreased to $0.10, primarily due to $1.9 million in costs from a newly acquired facility and heightened promotional expenses.
The company posted a pretax loss of $2.1 million, contrasted by $3 million in tax benefits that averted deeper losses.
Cash and short-term investments stand at $81 million with no debt, reflecting a strong balance sheet amid capital expenditures of $28 million year-to-date.
Shareholder returns included $13 million in Q3 via dividends and stock buybacks, with a declared dividend of $0.04 per share for Q3, representing roughly 40% of net income.
New product sales comprised 34% of net firearms sales, highlighting ongoing innovation despite a declining overall firearms market.

View recap

Sunrun Inc.

RUN Q3 2025

Reported: 2025-11-07

Sunrun delivered strong third-quarter results, achieving a 10% year-over-year growth in aggregate subscriber value, driven by a strategic focus on energy independence and customer-centric offerings.

Key takeaways

$1.6 billion in aggregate subscriber value, at the top end of guidance, with a 35% increase in contracted net value creation.
Generated $108 million in cash, marking the sixth consecutive quarter of positive cash generation and exceeding previous guidance.
Over 1.1 million customers served, with significant traction in innovative product offerings like Flex, boosting recurring cash flow.
Established a formidable power generation capacity with 3.7 gigawatt hours of dispatchable energy from home batteries and 8.2 gigawatts of solar capacity.
Anticipating rapid growth in cash flow as the company scales energy storage and solar offerings to meet increasing nationwide energy demands.

View recap

Recursion Pharmaceuticals, Inc.

RXRX Q3 2025

Reported: 2025-11-07

Recursion's Q3 2025 earnings report reflects strong operational momentum, highlighted by a significant milestone payment from Roche and a sustained cash balance to support future initiatives under new CEO, Najat Khan.

Key takeaways

Transition of leadership with Najat Khan stepping in as CEO on January 1, signaling a bold new strategic focus for the company.
Achieved $30 million milestone payment from Roche, contributing to over $0.5 billion in total cash inflows from partnerships—a notable accomplishment for a pre-commercial biotech firm.
Robust cash position of nearly $800 million, providing operational runway through 2027 without additional financing, enabling the pursuit of multiple upcoming catalysts.
Continued advancements in the neuro map and microglial cell projects, critical for developing novel therapeutics in neuroscience and oncology.

View recap

Rayonier Advanced Materials Inc.

RYAM Q3 2025

Reported: 2025-11-07

RYAM reported Q3 2025 earnings reflecting operational stabilization and strategic adjustments, resulting in refined full-year adjusted EBITDA guidance of $135 to $140 million.

Key takeaways

Adjusted EBITDA guidance for 2025 decreased due to proactive downtime in noncore production and weakened paperboard markets.
Continued success in Cellulose Specialties with normalized EBITDA margins, despite challenges in the fluff product segment due to tariffs impacting U.S. exports to China.
Operational challenges are being resolved, with key staffing roles filled to stabilize performance at the Tartas facility.
Strategic initiatives at the Temiscaming site aim to reduce costs and improve profitability, with new product developments underway expected to generate significant EBITDA contributions in 2026.
Trade conditions are improving for U.S. producers, with favorable developments in ongoing investigations regarding Brazilian and Norwegian imports, potentially leveling the competitive landscape.

View recap

Sabre Corporation

SABR Q3 2025

Reported: 2025-11-07

Sabre's Q3 2025 results reflect solid operational performance with a 3% revenue growth and significant progress in air distribution bookings, driven by strategic initiatives and improving market conditions.

Key takeaways

Total distribution bookings increased 3% YoY, with air distribution bookings up over 2%, bolstered by a strong performance in September.
Normalized adjusted EBITDA grew 23%, leading to an improved margin of 21%, demonstrating effective expense management.
The company expects to reduce net leverage by approximately 50% by the end of 2025 compared to year-end 2023, showcasing continued focus on deleveraging.
Sabre introduced AI-driven enhancements, including agentic APIs and the Continuous Revenue Optimizer, enhancing its competitive positioning in the travel industry.
Hotel distribution bookings grew 6%, with substantial progress in new agency partnerships and NDC integrations.

View recap

Sinclair Broadcast Group, Inc.

SBGI Q3 2025

Reported: 2025-11-07

Sinclair Broadcast Group achieved robust third-quarter results, surpassing revenue and EBITDA guidance while advancing strategic station acquisitions amidst a favorable regulatory backdrop for industry consolidation.

Key takeaways

Total revenue reached $773 million, exceeding guidance, with core revenues up 7% year-over-year.
Adjusted EBITDA of $100 million surpassed expectations, reflecting effective cost management.
Significant progress in station acquisitions, with 11 closed and 12 pending FCC approval, projected to generate an incremental $30 million in annual adjusted EBITDA.
The regulatory environment is shifting favorably for consolidation, with potential for significant synergies in the broadcast sector.
Early indicators suggest record midterm political advertising revenue in 2026, likely matching or exceeding the $333 million achieved in 2022.

View recap

Seadrill Limited

SDRL Q3 2025

Reported: 2025-11-07

Seadrill's Q3 2025 earnings reflect strong operational performance and strategic contract wins, contributing over $300 million to its backlog and solidifying its market leadership in Angola and the U.S. Gulf.

Key takeaways

Added over $300 million to backlog through new contracts for five rigs, enhancing revenue visibility through 2026.
Achieved exceptional technical uptime of over 99.7% for rigs in the Sonadrill joint venture.
Secured direct continuation contracts for the West Vela and Sevan Louisiana in the U.S. Gulf, underscoring strong customer relationships.
Highlighted commitment to operational excellence, with plans to enhance rig capabilities through new technologies like managed pressure drilling.
Positive market outlook with increasing global tendering activity and renewed focus on offshore investment by oil majors.

View recap

Vivid Seats Inc. Class A Common Stock

SEAT Q3 2025

Reported: 2025-11-07

Vivid Seats delivered a solid recovery in its third quarter, highlighted by a leadership transition and a renewed focus on enhancing its app value proposition, positioning the company for sustained long-term growth.

Key takeaways

App users showed double-digit sequential growth, contributing to a return to year-over-year gross order value (GOV) growth.
Leadership transition announced, with Lawrence Fey stepping in as CEO to drive the company’s strategic vision.
Significant cost reduction program doubled targets from $25 million to $60 million, with strong progress already made.
Corporate simplification executed to improve operational efficiency, yielding up to $180 million in potential tax savings.
Renewed ESPN partnership aims to expand brand awareness and reach through a national marketing campaign.

View recap

Senseonics Holdings, Inc.

SENS Q3 2025

Reported: 2025-11-07

Senseonics reported a robust 90% year-over-year revenue growth in Q3 2025, driven by surging demand for its Eversense 365 continuous glucose monitor and enhanced direct-to-consumer marketing initiatives.

Key takeaways

New patient shipments skyrocketed by 160% year-over-year, fueling record high quarterly new patient starts.
Strategic memorandum signed with Ascensia Diabetes Care to regain Eversense commercialization control, enhancing operational strategy.
Direct-to-consumer marketing efforts resulted in a 300% increase in patient leads year-over-year, with 60% of new patients sourced from DTC advertising.
The total number of providers prescribing Eversense grew by over 55% year-over-year, reflecting increased market penetration and confidence in the product.
Continued expansion of Eon Care's network, accounting for approximately 25% of nationwide insertions, is expected to bolster future access and adoption of Eversense 365.

View recap

Sezzle Inc. Common Stock

SEZL Q3 2025

Reported: 2025-11-07

Sezzle Inc. delivered strong third-quarter results with 67% year-on-year revenue growth and a net income margin exceeding 22%, reflecting robust demand and effective product enhancements.

Key takeaways

Revenue increased by 67% year-on-year, driven by the successful launch of new features aimed at enhancing consumer engagement.
Net income margin for Q3 surpassed 22%, while return on equity exceeded 100% over the past 12 months.
Significant growth in Monthly On-demand & Subscribers (MODS) metric, with almost 50% increase year-on-year, despite a slight drop in subscription user count.
Recent product features, including the Earn tab, received over 13 million visits, showcasing effective customer interaction and increased usage.
EPS and EBITDA guidance for 2025 have been raised, indicating confidence in future performance amid a growing BNPL market.

View recap

Sweetgreen, Inc.

SG Q3 2025

Reported: 2025-11-07

Sweetgreen reported Q3 2025 sales of $172.4 million, with a notable decline in same-store sales, as the company navigates operational challenges and focuses on a comprehensive transformation strategy.

Key takeaways

Same-store sales fell 9.5%, primarily due to weakened demand in the Northeast and Los Angeles markets.
Restaurant level margin was reported at 13.1%, while adjusted EBITDA reflected a loss of $4.4 million.
Initiatives under the "Sweet Growth Transformation Plan" include enhancing operational excellence and finalizing menu innovations to better engage customers.
Improvements in operational metrics were observed, with about 60% of restaurants now meeting internal performance standards.
Upcoming marketing campaigns will focus on brand relevance, particularly in challenged markets like New York, and will spotlight the quality of ingredients used in menu offerings.

View recap

Sight Sciences Inc. Common Stock

SGHT Q3 2025

Reported: 2025-11-07

Sight Sciences delivered a robust Q3 2025 with revenues of $19.9 million, driven by strong adoption of its interventional glaucoma technologies and exciting advancements in its dry eye treatment segment.

Key takeaways

Raised full-year 2025 revenue guidance to $76 million to $78 million, reflecting positive momentum.
Achieved key reimbursements in the TearCare segment with new fee schedules in place for over 10 million Medicare-covered lives.
Experienced sequential growth in Surgical Glaucoma revenue, indicating effective operational execution and market demand.
Targeted commercialization efforts underway for TearCare, with a focus on expanding market access and customer advocacy among 6,500 potential adopters.

View recap

Sangamo Therapeutics, Inc.

SGMO Q3 2025

Reported: 2025-11-07

Sangamo Therapeutics reported significant advancements in its clinical pipeline for Fabry disease, highlighted by promising data from its STAAR study and a positive interaction with the FDA regarding its upcoming BLA submission.

Key takeaways

Presented compelling clinical data from the STAAR study, showing durable benefits of ST-920, with a mean annualized eGFR slope of nearly 2 at 52 weeks across all patients.
FDA meeting confirmed agreement to use eGFR slope as an endpoint for an accelerated approval pathway, with plans for a BLA submission anticipated in early 2026.
Initiated the Phase I/II STAND study for chronic neuropathic pain, expanding Sangamo's reach into neurology.
Emphasized the strong safety profile and durable efficacy of ST-920, including encouraging cardiac data from treated patients.
Focused commitment to addressing unmet needs within the Fabry community, bolstered by patient engagement and feedback.

View recap

SIGA Technologies, Inc.

SIGA Q3 2025

Reported: 2025-11-07

SIGA Technologies reported a solid third quarter, with product revenues totaling approximately $86 million year-to-date, reflecting continued government engagement for smallpox antiviral procurement amid evolving bioterrorism concerns.

Key takeaways

Year-to-date product revenue was approximately $86 million, driven by strong oral and IV TPOXX sales.
Approximately $26 million in outstanding U.S. government orders, primarily for IV TPOXX, expected to be delivered in 2026.
Ongoing discussions regarding future procurement of TPOXX highlight the U.S. government's commitment to bioterrorism preparedness amidst a pending government shutdown.
SIGA is progressing on pediatric formulation development and an FDA submission for post-exposure prophylaxis (PEP) planned for 2026, despite some delays due to the shutdown.
International sales opportunities are anticipated for 2026 as global health security strategies evolve in response to bioterrorism threats.

View recap

Savaria Corporation

SIS.TO Q3 2025

Reported: 2025-11-07

Savaria Corporation achieved a record 21.2% adjusted EBITDA margin in Q3 2025, driven by operational improvements and strong performance in the Accessibility segment.

Key takeaways

Revenue rose 5.2% year-over-year to $224.8 million, aided by organic growth and acquisitions.
Gross margin improved by 220 basis points to 39.2%, reflecting successful operational efficiencies from the Savaria One initiative.
Q3 net earnings jumped 74% to $19.5 million, resulting in earnings per share of $0.27.
High backlog levels signal a strong Q4 outlook, despite overall growth being below targets.
Net debt-to-EBITDA ratio improved to 1.19, with $290 million available for future investments.

View recap

Stabilis Solutions, Inc.

SLNG Q3 2025

Reported: 2025-11-07

Stabilis Solutions reported a strong third quarter in 2025, achieving a 15% year-over-year revenue increase driven by robust demand in aerospace, marine, and power generation sectors.

Key takeaways

Revenue grew to $20.3 million, with LNG gallons sold up 21% year-over-year.
Aerospace revenues surged 88%, with marine and power generation up 32% and 31%, respectively.
Secured a historic 10-year marine bunkering contract, potentially representing 40% of planned LNG facility capacity in Galveston, Texas.
Adjusted EBITDA reached $2.9 million, reflecting a slight margin decline to 14.3% due to the conclusion of a high-margin industrial contract.
Strong liquidity of $15.5 million at quarter end, with a net positive cash position after debt obligations.

View recap

SLR Investment Corp.

SLRC Q3 2025

Reported: 2025-11-07

SLR Investment Corporation reported third-quarter net investment income of $0.40 per share, reflecting strong stability and a year-over-year increase in new originations, despite a competitive private credit landscape.

Key takeaways

Net income for Q3 was $0.43 per share, achieving a 9.4% annualized return on equity.
SLRC originated $447 million in new investments, a 12.7% increase year-over-year, marking the second highest quarter of originations in the company's history.
Approximately 93% of new originations were in specialty finance, enhancing the portfolio’s risk-adjusted return profiles and improving credit documentation integrity.
The organization is strategically focusing on asset-based lending (ABL) due to strong demand and high barriers to entry, successfully doubling ABL volume year-to-date compared to 2024.
The hiring of Mac Fowle as President of Asset-Based Lending reflects the firm's commitment to expanding its ABL capabilities amid growing opportunities in the private credit market.

View recap

Smith Micro Software, Inc.

SMSI Q3 2025

Reported: 2025-11-07

Smith Micro Software’s third-quarter results reflect a strategic reorganization aimed at enhancing efficiency and setting the stage for a return to profitability, despite a slight revenue decline year-over-year.

Key takeaways

Revenue decreased to $4.3 million, down 6% year-over-year and slightly below guidance due to delays in launching a new SafePath feature.
The company implemented strategic cost reductions expected to save approximately $7.2 million annually, affecting about 30% of its workforce.
Anticipates reaching breakeven by mid-2026, supported by a recent $2.7 million financing round to bolster operational efforts.
Strong pipeline growth in North America and Europe, with a focus on family subscribers representing a high-value market opportunity for carriers.

View recap

Sonos, Inc.

SONO Q4 2025

Reported: 2025-11-07

Sonos delivered a strong finish to fiscal 2025 with a 13% year-over-year revenue growth and positive adjusted EBITDA, all while laying the groundwork for a revitalized growth strategy.

Key takeaways

Revenues increased by 13% year-over-year, reflecting effective operational efficiencies and financial discipline.
The company announced the appointment of Colleen DeCourcy as the new Chief Marketing Officer, enhancing its leadership team.
Sonos is pivoting towards a unified sound system strategy aimed at integrating diverse audio experiences across households, setting the stage for long-term growth.
Average multiproduct households increased to 4.49, indicating strong consumer engagement; the company sees a pathway to significantly expand lifetime value within its existing customer base.
Sonos holds just 6% of the $24 billion global premium audio market, with ambitious plans to capture a larger share through innovative products and deeper customer relationships.

View recap

Sensus Healthcare, Inc.

SRTS Q3 2025

Reported: 2025-11-07

Sensus Healthcare's Q3 2025 performance showcases significant advancements, including the introduction of new CPT codes for superficial radiotherapy, which are expected to drive increased demand and enhanced reimbursement.

Key takeaways

CMS has established new dedicated CPT codes for superficial radiotherapy, promising over 300% reimbursement increases per treatment fraction.
The company recorded a 20% growth in FDA treatment volumes from Q2, marking the third consecutive quarter of double-digit growth; total treatments rose 157% since the program's launch.
Sensus shipped 16 SRT systems in Q3, reaching over 900 systems sold globally, with an expectation to hit 1,000 by 2026.
Strong cash position increased to $24.5 million, aided by improved working capital management, positioning the company to meet anticipated demand.

View recap

TBC Bank Group PLC

TBCG.L Q3 2025

Reported: 2025-11-07

TBC delivered a robust 6% year-on-year net profit growth to GEL 368 million in Q3 2025, marking a record quarterly performance, driven by strong returns in both Georgia and Uzbekistan.

Key takeaways

Return on equity stood at an impressive 24.4%, with Georgia’s return at over 24% and Uzbekistan’s exceeding 23%.
Revenue rose by 7% year-on-year, supported by a 9% increase in gross loans in Georgia and a nearly doubled loan book in Uzbekistan.
The digital ecosystem thrived, boasting nearly 22 million registered users and 1.2 million monthly active users in Georgia, indicating strong customer engagement.
The Board declared a quarterly dividend of GEL 1.75 per share, totaling GEL 5 for the first nine months of 2025.
Despite challenges in Uzbekistan impacting net profit guidance, the management remains optimistic about long-term growth potential.

View recap

BlackRock TCP Capital Corp.

TCPC Q3 2025

Reported: 2025-11-07

BlackRock TCP Capital Corp. maintained its NAV at $8.71 in Q3 2025 while improving nonaccruals to 3.5% of the portfolio, although challenges with the Renovo investment may impact future earnings.

Key takeaways

Successful resolution of challenged credits with a drop in nonaccrual investments from 5.6% to 3.5%.
Declared a consistent third-quarter dividend of $0.25 per share, reflecting stability amid market fluctuations.
Increased deal activity with a 20% rise in reviewed opportunities, showcasing enhanced access through the BlackRock and HPS Private Financing Solutions platform.
Notable portfolio gains, particularly with NEP Group, which upgraded TCPC's investment from a second lien to a first lien term loan.
Anticipated write-down of the Renovo investment, projected to reduce NAV by approximately $0.15 per share in Q4 2025.

View recap

Tecnoglass Inc.

TGLS Q3 2025

Reported: 2025-11-07

Tecnoglass posted a record revenue of $260.5 million in Q3 2025, reflecting a 9.3% year-over-year increase driven by strong performance in both residential and commercial segments, despite ongoing macroeconomic challenges.

Key takeaways

Single-family residential revenue grew 3.4% year-over-year to $113.5 million, aided by recently implemented pricing initiatives.
Multifamily and commercial revenue surged 14.3% year-over-year to $147 million, contributing to a record backlog of $1.3 billion, up over 20%.
Maintained strong profitability with a gross margin of 42.7% and an adjusted EBITDA margin of 30.4%.
Returned significant capital to shareholders, repurchasing $30 million in shares and paying $7 million in dividends during the quarter.
Healthy book-to-bill ratio remained at 1.3x, demonstrating consistent order activity and market share gains.

View recap

Alpha Teknova Inc. Common Stock

TKNO Q3 2025

Reported: 2025-11-07

Teknova reported robust financial performance in Q3 2025, with a 9% year-over-year revenue growth driven primarily by strong sales in its Lab Essentials segment, indicating sustained operational excellence.

Key takeaways

Revenue reached $10.5 million, up from $9.6 million in Q3 2024, marking the fifth consecutive quarter of growth.
Lab Essentials revenue grew 16% to $8.3 million, reflecting a healthy increase in average revenue per customer.
Clinical Solutions revenue decreased 13% to $1.7 million due to lower average revenue per customer, although customer count increased.
Operational enhancements are underway, anticipated to improve efficiency and scale revenue to over $200 million by 2026 without significant capex.
Continued focus on expanding the Clinical Solutions customer base expected to drive long-term growth through to 2026 and beyond.

View recap

TKO Group Holdings, Inc.

TKO Q3 2025

Reported: 2025-11-07

TKO reported a transformative Q3 2025, highlighted by landmark media rights agreements, a 100% increase in cash dividends, and a $1 billion stock buyback, reinforcing strong growth trajectories across its operations.

Key takeaways

Secured a historic 7-year, $7.7 billion media rights deal with Paramount for UFC, doubling previous average annual value.
Launched a 5-year partnership with ESPN for WWE, resulting in over 1.8x increase in value and expanding audience reach.
Established records in live events, with UFC and WWE achieving significant ticket sales and audience viewership milestones.
Continued strong performance in brand partnerships, with WWE attracting major new sponsors and PBR delivering record viewership on CBS.
Increased full-year guidance signals confidence in sustainable long-term growth amid a robust sports content landscape.

View recap

Tandem Diabetes Care, Inc.

TNDM Q3 2025

Reported: 2025-11-07

Tandem Diabetes Care reported record Q3 sales, driven by significant advancements in commercial operations and successful product launches, positioning the company for future growth.

Key takeaways

Record Q3 sales driven by improved sales productivity and an effective commercial transformation in the U.S.
Successful launch of t:slim X2 with Abbott's FreeStyle Libre 3 Plus integration, enhancing user access to advanced diabetes management technology.
Expansion of Type 2 diabetes efforts showing promising results, doubling the company's addressable market in the U.S.
Direct sales initiatives in Europe slated to begin in early 2026, enhancing growth potential and margin expansion.
Increased pharmacy benefit coverage for Tandem Mobi reaching over 40% of U.S. lives, marking a significant milestone in revenue generation.

View recap

Texas Pacific Land Corporation

TPL Q3 2025

Reported: 2025-11-07

Texas Pacific Land Corporation achieved record revenue of over $200 million in Q3 2025, driven by substantial growth in oil and gas royalties and water sales, despite challenging benchmark pricing.

Key takeaways

Oil and gas royalty production reached a record 36,300 barrels of oil equivalent per day, marking a 28% year-over-year increase.
Water sales revenue soared to $45 million, representing a 74% sequential growth and a 23% increase year-over-year.
Produced water royalty revenues grew to $32 million, up 16% year-over-year.
The company's strategy of acquiring mineral and royalty interests is yielding a mid-teens pretax cash flow yield.
TPL's investments in water infrastructure position it as a key player in the Permian Basin, solidifying market share despite industry headwinds.

View recap

Targa Resources Corp.

TRGP Q3 2025

Reported: 2025-11-07

Targa Resources Corporation achieved record adjusted EBITDA in Q3 2025, driven by strong Permian volume growth and continued commercial success, positioning the company for significant future cash flow generation.

Key takeaways

Adjusted EBITDA for the quarter is expected to be at the top end of guidance due to record natural gas inlet volumes averaging 6.6 billion cubic feet per day.
NGL volumes increased by approximately 180,000 barrels per day year-over-year, highlighting robust demand and operational efficiency.
Multiple new growth projects announced, including the Speedway NGL transportation expansion and Copperhead gas processing plant, set to enhance capacity and support future growth.
Long-term projections indicate a durable increase in free cash flow beginning in 2027 as capital expenditures decrease, despite ongoing growth investments.
Strong customer relationships and market positioning forecasted to sustain low double-digit volume growth through 2026.

View recap

Tronox Holdings plc

TROX Q3 2025

Reported: 2025-11-07

Tronox Holdings plc reported a challenging Q3 2025 with a 13% decline in revenues to $699 million, driven by weaker demand and competitive pressures in the TiO2 and zircon markets, leading to a net loss of $99 million.

Key takeaways

Secured $400 million in senior secured notes, enhancing liquidity amidst ongoing market challenges.
Cost improvement program ahead of schedule, expected to achieve over $60 million in annualized savings by year-end 2025.
Anticipated operational adjustments, including idling plants and reducing inventory, projected to yield $25 million to $30 million in cash benefits in Q4.
Continued pressure observed in TiO2 and zircon sales, with revenues down 11% and 20% year-over-year, respectively.
Strategic focus on diversifying supply chains and capitalizing on potential rare earth mineral opportunities.

View recap

trivago N.V.

TRVG Q3 2025

Reported: 2025-11-07

Trivago reported robust Q3 2025 results with a 13% year-over-year revenue increase and 18% growth in adjusted EBITDA, demonstrating sustained momentum despite foreign exchange challenges.

Key takeaways

Achieved 13% revenue growth, marking the fourth consecutive quarter of double-digit growth.
Strong branded traffic revenue, with significant marketing efficiency improvements from new AI-powered initiatives featuring brand ambassador Jürgen Klopp.
Confidence maintained for mid-teens revenue growth for the full year and positive adjusted EBITDA of at least EUR 10 million.
Enhanced hotel search experience and continued investment in partnerships to create value amid economic uncertainties.
Expect a promising Q4, bolstered by a disciplined strategy focusing on core markets and optimization ahead of a winter marketing campaign.

View recap

The Trade Desk, Inc.

TTD Q3 2025

Reported: 2025-11-07

The Trade Desk reported robust Q3 2025 performance with revenue growth of 18%, driven primarily by the significant expansion in its Connected TV (CTV) and retail media segments.

Key takeaways

Revenue increased by 18% year-over-year; 22% growth excluding political spend.
CTV remains the fastest-growing channel, projected to dominate programmatic buying models.
Rapid growth of retail media indicates strong adoption of programmatic advertising across various verticals.
The shift toward an open Internet fosters competitive supply chains, enhancing price discovery and advertiser value.
AI innovations are bolstering effectiveness and efficiency in digital advertising, shifting focus away from walled gardens.

View recap

10x Genomics, Inc.

TXG Q3 2025

Reported: 2025-11-07

10X Genomics reported a solid third quarter, exceeding revenue expectations with $149 million driven by strong demand for both single-cell and spatial biology products despite ongoing macroeconomic challenges.

Key takeaways

Total revenue of $149 million surpassed guidance, reflecting strong execution amid macro pressures.
Significant year-over-year growth in spatial consumables, particularly for Xenium, continued to drive momentum.
Expansion of product offerings, including new Chromium Flex and Xenium protein, is anticipated to enhance market adoption and streamline workflows.
Ended the quarter with a robust $482 million cash position, ensuring flexibility for strategic investments.
Customer sentiment indicates sustained cautious spending behavior, particularly concerning capital expenditures.

View recap

Texas Roadhouse, Inc.

TXRH Q3 2025

Reported: 2025-11-07

Texas Roadhouse delivered record third-quarter revenues of $1.4 billion, driven by strong same-store sales growth and successful expansion efforts across its restaurant brands.

Key takeaways

Revenue increased significantly, achieving the highest quarterly growth of the year alongside strong traffic and same-store sales.
Seven new company-owned locations opened in Q3, contributing to a projected total of approximately 30 new restaurants for 2025.
Despite rising commodity prices, especially for beef, there was no significant impact on guest behavior post-menu price increase, indicating robust consumer demand.
Continued momentum in the To-Go business and retail strategy, with presence across 120,000 retail outlets bolstering brand visibility.
Cash flow from operations rose to $144 million, supporting ongoing development and capital allocation strategies.

View recap

Unisys Corporation

UIS Q3 2025

Reported: 2025-11-07

Unisys Corporation demonstrated resilience in Q3 2025, outperforming operating margin expectations while navigating revenue headwinds largely due to timing issues and macroeconomic uncertainty.

Key takeaways

Achieved non-GAAP operating profit margin guidance of 8% to 9%, with full-year pre-pension free cash flow expected to reach $110 million.
Increased License & Support (L&S) revenue expectations to $430 million for the year, driven by strong client retention and software consumption trends.
Total contract value for new business increased 15% year-over-year, suggesting solid client renewals despite a challenging pricing environment.
Continued focus on pension strategy led to a significant reduction in U.S. pension liabilities, with over $300 million removed through an annuity purchase.
Adjustments in project timing and client budget constraints may impact near-term revenue growth, although a long-term growth strategy remains in place.

View recap

Frontier Group Holdings, Inc.

ULCC Q3 2025

Reported: 2025-11-07

Frontier Group Holdings reported a commendable third quarter for 2025, with revenue growth driven by improved efficiencies and a strategic reduction in capacity. Despite competitive pressures, the company anticipates a favorable shift in the market landscape.

Key takeaways

Total revenue increased to $886 million, with revenue per passenger up 1% year-over-year amid 4% lower capacity.
The operational reliability is underscored by a completion factor ranking third among domestic carriers for September.
Announced 42 new routes, targeting expansion in major U.S. metros and new international destinations through early 2026.
Loyalty program revenues per passenger surged over 40% year-over-year, reflecting successful enhancements aimed at higher-income customers.
Liquidity remained solid at $691 million, with additional financing secured through a $105 million note issuance related to spare parts and tooling.

View recap

Unusual Machines, Inc.

UMAC Q3 2025

Reported: 2025-11-07

Unusual Machines reported its first profitable quarter with record revenues of $2.1 million, marking a strategic shift towards enterprise sales and a gross margin expansion.

Key takeaways

Achieved $2.1 million in quarterly revenue, a 39% increase year-over-year, with year-to-date revenue up 55% at $6.3 million.
First quarter where over 50% of revenue originated from enterprise sales, with $16 million in future purchase orders secured.
Gross margin improved from 28% to 34% year-to-date, reflecting successful transition from retail to enterprise focus.
Cash balance strengthened to over $130 million, after raising $72 million through an ATM offering, providing ample liquidity for growth initiatives.
Employee headcount increased from 19 to over 60, showcasing rapid scaling in line with expanding operational demands.

View recap

UroGen Pharma Ltd.

URGN Q3 2025

Reported: 2025-11-07

UroGen Pharma reported strong third-quarter results, with a notable increase in ZUSDURI's preliminary demand, setting the stage for future growth in an estimated $5 billion market.

Key takeaways

October's preliminary demand revenue for ZUSDURI more than doubled compared to the previous three months, indicating a solid uptick in adoption.
JELMYTO achieved $25.7 million in net product revenue, a 13% increase year-over-year, illustrating sustained market confidence.
The positive clinical performance of ZUSDURI, with an 80% complete response rate at three months, positions it as a likely standard of care for bladder cancer.
UroGen is on track to submit a New Drug Application (NDA) for UGN-103 in the second half of 2026, with FDA approval anticipated in 2027.
Anticipation of a permanent product-specific J-code for ZUSDURI effective January 1, 2026, could accelerate adoption and reimbursement processes.

View recap

US Foods Holding Corp.

USFD Q3 2025

Reported: 2025-11-07

US Foods Holding Corporation reported strong Q3 2025 results, with net sales growth of 4.4% and a notable 10.9% increase in adjusted EBITDA, reflecting solid execution and a successful market position.

Key takeaways

Achieved 29 basis points of adjusted EBITDA margin expansion and a 26.7% growth in adjusted EPS year-to-date.
Independent case volume grew 3.9%, with strong momentum and a net new account growth rate of 4.4%, marking the highest since Q2 2023.
Announced acquisition of Shetakis, an independent food distributor in Las Vegas, aligning with the company’s strategic M&A focus.
Improved safety metrics with a 16% reduction in injury and accident rates, reinforcing corporate commitment to associate well-being.

View recap

Wynn Resorts, Limited

WYNN Q3 2025

Reported: 2025-11-07

Wynn Resorts reported a solid Q3 2025 performance, with significant growth in gaming revenues and strong EBITDAR driven by market share gains across its key locations, despite some operational challenges.

Key takeaways

Wynn Las Vegas achieved EBITDA growth of 3% to $211 million, with casino revenues up 10% and a strategic focus on preserving ADR contributing to flat hotel revenue.
Encore Boston Harbor generated $58 million in EBITDAR, with slot revenues increasing over 5% year-on-year amidst controlled operating expenses.
Macau operations delivered $308 million in EBITDAR, bolstered by a VIP hold benefit, with mass volumes up 15% year-on-year despite weather disruptions.
Upcoming projects, including expansions in Macau and the development of Wynn Al Marjan Island, position the company for future growth and capitalize on rising premium market demand.
While facing some expected headwinds from property renovations, the long-term outlook remains positive, bolstered by strong demand signals in Las Vegas and Macau.

View recap

Block, Inc.

XYZ Q3 2025

Reported: 2025-11-07

Block's Q3 2025 results surpassed expectations, driven by a robust 18% year-over-year growth in gross profit, predominantly fueled by Cash App's expanding user base and product offerings.

Key takeaways

Gross profit reached $2.66 billion, a notable acceleration from previous quarters, primarily thanks to a 24% increase in Cash App's gross profit.
Cash App's monthly active users grew to 58 million, bolstered by enhancements in user experience and engagement initiatives.
New financial products, including expanded Cash App Borrow and the post-purchase Buy Now Pay Later feature, achieved significant momentum with a 134% year-over-year growth in loans.
Square's gross profit rose 9% year-over-year as the company strengthened its market position among larger sellers and in international markets.
Introducing AI-driven tools and integrated solutions, Block aims to enhance seller operations and improve service delivery, positioning itself favorably for future growth.

View recap

Yelp Inc.

YELP Q3 2025

Reported: 2025-11-07

Yelp Inc. reported strong Q3 2025 results with record net revenue of $376 million, driven by a 7% year-over-year increase in Services revenue, despite challenges in the Restaurant, Retail, and Other categories.

Key takeaways

Net income rose 2% year-over-year to $39 million, maintaining a 10% net income margin.
Adjusted EBITDA margin stood at 26%, with efficacy driven by disciplined expense management.
Significant growth in AI-led initiatives, including a 400% increase in project submissions via Yelp Assistant.
New partnership with DoorDash expands food ordering capabilities to over 500,000 restaurants, expected to generate incremental revenue.
Overall decline of 2% in RR&O revenue indicates persistent macro pressures, affecting paying advertising locations.

View recap

Zai Lab Limited

ZLAB Q3 2025

Reported: 2025-11-07

Zai Lab's Q3 2025 results reflect strong advancements in its clinical pipeline, particularly the promising early data for Zoci, while the company's commercial operations in China demonstrate steady growth despite a complex environment.

Key takeaways

Zoci (ZL-1310) shows a 68% overall response rate and 94% disease control rate in heavily pretreated extensive stage small cell lung cancer patients, suggesting strong efficacy potential.
The company is on track for its first global approval by 2027 or early 2028, with ongoing enrollment in registrational Phase III trials.
Zai Lab reports continued profitability within its commercial business in China, although growth is at a slower pace than anticipated amid a dynamic market.
Significant advancements in the pipeline include the entry of IL-13/IL-31 bispecific antibody into Phase I and continued progress with innovative assets and late-stage programs.
The company emphasizes a commitment to delivering impactful therapies and long-term value for shareholders while navigating regulatory and competitive challenges.

View recap

Earnings Recaps

Airbnb, Inc.

Archer Aviation Inc. Class A Common Stock

Ameren Corporation

Air France-KLM SA

Aflac Incorporated

Assured Guaranty Ltd.

a.k.a. Brands Holding Corp.

Alpha Services and Holdings S.A.

Amprius Technologies, Inc.

Alpha Metallurgical Resources, Inc.

Aemetis, Inc.

Artivion Inc. Common Stock

Air Products and Chemicals, Inc.

AppLovin Corporation

Appian Corporation

Arhaus Inc. Class A Common Stock

Atmos Energy Corporation

AvePoint Inc. Class A Common Stock

Barrett Business Services, Inc.

Black Hills Corporation

BlackSky Technology Inc.

BK Technologies Corporation

Bloomin' Brands, Inc.

Blink Charging Co.

Borr Drilling Limited

Bowman Consulting Group Ltd. Common Stock

Commerzbank AG

CareCloud Inc. Common Stock

Chimera Investment Corporation

Clarus Corporation

ConocoPhillips

Corpay, Inc.

RH

Cresco Labs Inc.

Carriage Services, Inc.

CoreCivic, Inc.

Box, Inc.

Definitive Healthcare Corp. Class A Common Stock

Dine Brands Global, Inc.

Krispy Kreme Inc. Common Stock

DigitalOcean Holdings, Inc.

electroCore, Inc.

Flex Ltd.

Eos Energy Enterprises, Inc.

Eversource Energy

Esperion Therapeutics, Inc.

Evaxion Biotech A/S

Evergy, Inc.

Expensify Inc. Class A Common Stock

Expedia Group, Inc.

Simplify Macro Strategy ETF

Leonardo S.p.a.

Five9, Inc.

Flowers Foods, Inc.

Funko, Inc.

Fresenius SE & Co. KGaA

JFrog Ltd.

FRP Holdings, Inc.

Fortuna Silver Mines Inc.

Fortinet, Inc.

Genpact Limited

GDI Integrated Facility Services Inc.

Grupo Financiero Banorte, S.A.B. de C.V.

Global Net Lease, Inc.

Genworth Financial, Inc.

Gold Resource Corporation

GeoPark Limited

Grifols, S.A.

Knight Therapeutics Inc.

Hyatt Hotels Corporation

Harvard Bioscience, Inc.

Henkel AG & Co. KGaA

Heritage Insurance Holdings, Inc.

International Consolidated Airlines Group, S.A.

iA Financial Corporation Inc.

International Consolidated Airlines Group, S.A.

Intact Financial Corporation

International Seaways, Inc.

Inuvo, Inc.